Sacroiliitis, not elsewhere classified

M13_SACROILIITIS

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — M46.1 Hospital discharge: ICD-9 — 7202 Hospital discharge: ICD-8 — 72699 Cause of death: ICD-10 — M46.1 Cause of death: ICD-9 — 7202 Cause of death: ICD-8 — 72699 2 out of 7 registries used, show all original rules.	2306
4. Check minimum number of events None	2306
5. Include endpoints None	2306
6. Filter based on genotype QC (FinnGen only)	2103

Control definitions (FinnGen only)

Control exclude: M13_DORSOPATHY

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: M46
Name in latin: Sacroiliitis non alibi classificata

NAME	M13_SACROILIITIS
CONTROL_EXCLUDE	M13_DORSOPATHY
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	M461
HD_ICD_9	7202
HD_ICD_8	72699
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	M461
COD_ICD_9	7202
COD_ICD_8	72699
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Sacroiliitis, not elsewhere classified based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	11257	6845	4374
Only index persons	10866	6650	4216
Unadjusted period prevalence (%)
Whole population	0.17	0.20	0.12
Only index persons	0.21	0.24	0.16
Median age at first event (years)
Whole population	36.39	38.05	33.77
Only index persons	36.06	37.77	33.36

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2103	1461	642
Unadjusted period prevalence (%)	0.45	0.52	0.29
Median age at first event (years)	38.05	38.02	38.13

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2201: Matched controls
22010

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

9.7

323.3

419

523

M54.5

ICD-10 Finland

Low back pain

5.6

307.7

1228

4022

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

45.5

307.7

677

213

M46.9

ICD-10 Finland

Inflammatory spondylopathy, unspecified

902.2

307.7

436

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

47.0

307.7

600

174

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

36.3

307.7

1358

936

M54.4

ICD-10 Finland

Lumbago with sciatica

7.5

307.7

606

1064

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

13.9

307.7

349

294

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

61.0

307.7

205

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

186.7

307.7

579

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

31.6

307.7

359

135

L04AB06

ATC

golimumab; parenteral

53.1

307.7

194

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

43.2

307.7

685

228

M54.9

ICD-10 Finland

Dorsalgia, unspecified

8.3

307.7

578

910

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

13.7

307.7

615

607

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

30.8

307.7

428

171

L04AB04

ATC

adalimumab; parenteral

25.6

307.7

420

201

L88

ICPC

Rheumatoid/seropositive arthritis

17.9

307.7

425

291

L04AB01

ATC

etanercept; parenteral

33.5

307.7

289

L04AX03

ATC

methotrexate; systemic

12.2

307.7

777

941

M46.1

ICD-10 Finland

Sacroiliitis, not elsewhere classified

27084.9

307.7

2106

M45

ICD-10 Finland

Ankylosing spondylitis

1117.9

307.7

915

A07EC01

ATC

sulfasalazine; oral, rectal

60.2

307.7

1380

598

M48.0

ICD-10 Finland

Spinal stenosis

31.1

276.9

183

M01AH05

ATC

etoricoxib; oral

5.8

254.9

1801

9616

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

12.0

250.2

266

250

M01AH01

ATC

celecoxib; oral

5.6

246.7

566

1274

N03AX12

ATC

[U] gabapentin; oral

6.5

230.3

430

795

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

19.0

229.9

185

106

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

49.3

223.5

130

N03AX16

ATC

[U] pregabalin

5.1

219.3

565

1395

N02AX02

ATC

tramadol; systemic, rectal

3.9

216.8

1053

4158

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

24.3

211.2

152

L04AC10

ATC

secukinumab; parenteral

53.2

202.7

116

M01AC06

ATC

meloxicam; systemic, rectal

3.7

194.4

981

3915

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

7.6

186.8

285

423

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

12.4

185.6

189

165

L01BA01

ATC

methotrexate; systemic

10.2

179.5

211

227

L04AB05

ATC

certolizumab pegol; parenteral

35.4

175.7

111

H02AB06

ATC

prednisolone; systemic

3.4

172.9

1270

6289

M47.82

ICD-10 Finland

Other spondylosis, cervical region

28.0

164.8

112

L03

ICPC

Low back symptom/complaint

3.4

162.7

880

3592

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

85.1

154.9

NA6CG

NOMESCO Finland

Sacro-iliac joint extensive MRI examination with high intensity magnet

209.7

152.0

156

M13.9

ICD-10 Finland

Arthritis, unspecified

5.4

142.8

308

640

GD1AA

NOMESCO Finland

Thorax X-ray examination

3.0

139.8

1062

5182

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

2.9

128.8

1083

5518

M47.9

ICD-10 Finland

Spondylosis, unspecified

64.7

125.0

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

17.8

124.4

102

M03BX02

ATC

tizanidine; oral

3.1

123.0

1572

9903

M54.6

ICD-10 Finland

Pain in thoracic spine

5.2

120.3

271

582

M25.5

ICD-10 Finland

Pain in joint

2.8

118.1

954

4707

A02BC02

ATC

pantoprazole; systemic

2.9

114.0

1564

10038

M03BC01

ATC

orphenadrine (citrate); systemic

3.1

114.0

629

2518

M54.3

ICD-10 Finland

Sciatica

8.9

113.7

146

175

M79.0

ICD-10 Finland

Rheumatism, unspecified

10.6

113.0

126

125

M43.1

ICD-10 Finland

Spondylolisthesis

20.8

112.9

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

13.6

108.9

103

N06AX21

ATC

duloxetine; oral

4.0

105.0

338

957

G55.1*M51.1

ICD-10 Finland

Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions

21.0

101.6

N02AJ06

ATC

codeine and paracetamol; systemic

2.6

101.6

1073

5933

M54.8

ICD-10 Finland

Other dorsalgia

6.7

100.9

167

267

N02BF01

ATC

gabapentin; oral

4.6

98.7

256

615

M54.1

ICD-10 Finland

Radiculopathy

13.6

98.5

M70.6

ICD-10 Finland

Trochanteric bursitis

3.8

93.4

315

918

H20.1

ICD-10 Finland

Chronic iridocyclitis

13.1

90.1

M46.8

ICD-10 Finland

Other specified inflammatory spondylopathies

+∞

89.2

M54

ICD-10 Finland

Dorsalgia

3.2

88.7

417

1500

M79.7

ICD-10 Finland

Fibromyalgia

6.9

88.7

142

219

L86

ICPC

Back syndrome with radiating pain

6.0

87.3

162

290

P01BA02

ATC

hydroxychloroquine; oral

4.1

86.5

262

706

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

7.9

86.2

121

161

UJF32

NOMESCO Finland

Coloscopy

2.8

86.0

541

2286

M01AB05

ATC

diclofenac; systemic, rectal

2.5

85.7

1511

10259

M01AE02

ATC

naproxen; oral, rectal

2.4

81.0

1430

9601

L04AA13

ATC

[U] leflunomide

8.3

79.3

106

133

A02BC03

ATC

lansoprazole; oral

2.6

77.6

582

2670

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

10.0

77.3

M35.7

ICD-10 Finland

Hypermobility syndrome

9.9

74.9

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

118.5

74.4

M01AH02

ATC

rofecoxib; oral

3.8

73.4

242

690

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.4

72.6

652

3241

H20.9

ICD-10 Finland

Iridocyclitis, unspecified

10.3

70.2

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

22.7

69.6

ABC16

NOMESCO Finland

Microsurgical excision of lumbar intervertebral disc displacement

+∞

69.1

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

4.1

67.3

196

511

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

9.4

66.3

A02BC05

ATC

esomeprazole; systemic

2.2

66.1

867

5020

M54.2

ICD-10 Finland

Cervicalgia

4.0

65.4

197

526

N06AA09

ATC

amitriptyline; systemic

4.1

64.8

187

484

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.4

64.6

569

2784

M79.6

ICD-10 Finland

Pain in limb

2.1

64.4

1011

6260

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

16.3

63.4

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.1

60.2

923

5626

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

5.8

58.5

109

195

N02BE01

ATC

paracetamol; systemic, rectal

3.0

58.3

1969

16244

H02AB07

ATC

prednisone; oral

2.9

57.7

311

1191

N02BF02

ATC

pregabalin; oral

4.2

57.4

163

416

H22.1*M45

ICD-10 Finland

Iridocyclitis in ankylosing spondylitis

+∞

56.5

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

8.1

55.6

M75.1

ICD-10 Finland

Rotator cuff syndrome

2.3

55.5

503

2472

72699

ICD-8 Finland

Affection of sacro-iliac joint

+∞

55.4

WZA10

NOMESCO Finland

Extensive medical or dental certificate

9.0

55.4

M03BC51

ATC

orphenadrine, combinations; systemic

2.2

55.3

611

3260

A07EC02

ATC

mesalazine; oral, rectal

3.7

55.3

188

545

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.3

54.8

534

2706

M01AX17

ATC

nimesulide; oral

2.5

54.0

406

1834

NA6BG, ,

SPAT

19.4

53.7

M53.1

ICD-10 Finland

Cervicobrachial syndrome

2.8

52.9

307

1220

S01FA04

ATC

cyclopentolate; ophthalmic

11.5

52.8

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

8.3

52.7

M02.9

ICD-10 Finland

Reactive arthropathy, unspecified

6.7

52.5

129

A07EA06

ATC

budesonide; oral, local oral

4.3

52.1

142

351

S01BA04

ATC

prednisolone; ophthalmic

7.4

51.4

104

NA6AA

NOMESCO Finland

Sacro-iliac joint X-ray examination

67.3

51.4

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

2.0

51.1

1014

6665

A01

ICPC

Pain general/multiple sites

3.1

50.6

229

793

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

6.1

50.1

152

L84

ICPC

Back syndrome without radiat pain

4.2

49.4

137

343

NF1AA

NOMESCO Finland

Hip X-ray examination

3.9

49.4

151

406

J01.0

ICD-10 Finland

Acute maxillary sinusitis

2.0

49.4

730

4318

O99.89

ICD-10 Finland

Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium

4.8

49.1

114

248

Z01.8

ICD-10 Finland

Other specified special examinations

2.2

48.6

496

2546

7202A

ICD-9 Finland

Ankylosing spondylitis and other inflammatory spondylopathies, Sacro-iliitis, not elsewhere classified

+∞

48.1

UJF30

NOMESCO Finland

Ileoscopy through colon

2.8

47.9

269

1049

M01AE03

ATC

ketoprofen; systemic, rectal

2.0

47.5

674

3920

S01FA02

ATC

scopolamine; ophthalmic

17.2

47.1

M50.3

ICD-10 Finland

Other cervical disc degeneration

16.3

47.0

R4110

NOMESCO Finland

Physiotherapy

2.1

47.0

552

2991

S01BA01

ATC

dexamethasone; ophthalmic

4.9

46.6

105

223

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

2.9

46.0

232

853

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

+∞

46.0

TNG10

NOMESCO Finland

Puncture of knee

9.0

45.9

M01AH03

ATC

valdecoxib; oral

4.1

45.2

129

330

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

6.7

45.2

110

M46.0

ICD-10 Finland

Spinal enthesopathy

160.0

45.0

J01AA02

ATC

doxycycline; systemic

2.0

44.8

1604

12602

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

2.8

44.1

249

972

M01AX01

ATC

nabumetone; oral

5.3

43.1

175

S01CA02

ATC

prednisolone and antiinfectives; ophthalmic

13.0

42.6

N02AA05

ATC

oxycodone; systemic

2.7

42.6

255

1025

H57.1

ICD-10 Finland

Ocular pain

3.6

41.9

147

434

ZX120

NOMESCO Finland

Intravenous

2.9

41.8

215

798

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

9.1

41.7

A02BC01

ATC

omeprazole; systemic

2.1

41.3

514

2828

L04AX01

ATC

azathioprine; systemic

3.6

41.3

141

409

NE1AA

NOMESCO Finland

Pelvis X-ray examination

3.9

41.2

123

325

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

3.3

41.0

160

506

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

8.1

40.2

N02AJ13

ATC

tramadol and paracetamol; systemic

7.4

39.9

K50.0

ICD-10 Finland

Crohn disease of small intestine

5.8

39.3

130

K50.9

ICD-10 Finland

Crohn disease, unspecified

6.0

39.2

120

H02AB04

ATC

methylprednisolone; systemic

2.4

38.8

294

1320

R51.80

ICD-10 Finland

Headache

2.1

38.5

412

2136

M01AB55

ATC

diclofenac, combinations; oral

4.1

38.0

108

275

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

4.0

37.9

111

289

7227C

ICD-9 Finland

Intervertebral disk disorders, Intervertebral disk disorder with myelopathy[SYNDROMA ISCHIADICUM]

+∞

37.6

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.9

37.2

634

3869

R06.0

ICD-10 Finland

Dyspnoea

2.0

37.0

484

2699

R52.9

ICD-10 Finland

Pain, unspecified

2.6

36.8

237

985

G44.2

ICD-10 Finland

Tension-type headache

2.2

36.4

340

1667

A02BA02

ATC

ranitidine; systemic

2.3

35.9

307

1450

L13

ICPC

Hip symptom/complaint

2.2

35.0

329

1616

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.9

34.7

177

653

J01MA02

ATC

ciprofloxacin; systemic

1.8

34.3

700

4501

Z3226

NOMESCO Finland

Physiotherapist

2.2

34.1

339

1701

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

2.5

33.9

227

960

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.8

33.8

739

4843

L02

ICPC

Back symptom/complaint

2.3

33.7

273

1259

4AB02, ,

NOMESCO Finland

11.9

33.4

K50.8

ICD-10 Finland

Other Crohn disease

5.3

33.4

132

H20

ICD-10 Finland

Iridocyclitis

9.7

33.3

R52.2

ICD-10 Finland

Other chronic pain

4.3

33.0

205

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.3

32.9

262

1199

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

3.4

32.8

121

369

G56.0

ICD-10 Finland

Carpal tunnel syndrome

2.3

32.7

277

1301

L04AB02

ATC

infliximab; parenteral

8.3

32.5

R42

ICD-10 Finland

Dizziness and giddiness

2.0

32.4

411

2256

L28

ICPC

Limited function/disability (L)

2.3

32.3

269

1254

Z01.0

ICD-10 Finland

Examination of eyes and vision

2.0

31.5

372

1989

SPAT1153

SPAT

Removal of sutures

1.9

31.5

522

3133

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

6.8

31.5

WZC30

NOMESCO Finland

Teaching

2.1

31.5

328

1674

R03AC02

ATC

salbutamol; inhalant

1.7

31.5

1208

9198

SPAT1249

SPAT

Treatment-related counselling outside office

1.7

31.4

847

5867

M02AA07

ATC

piroxicam; topical

1.8

31.1

569

3519

M79.1

ICD-10 Finland

Myalgia

2.0

30.8

371

1998

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

4.6

30.7

166

NA3BG, ,

SPAT

3.4

30.7

112

339

R50.9

ICD-10 Finland

Fever, unspecified

2.1

30.6

343

1799

ZXX01

NOMESCO Finland

Extent of proceudre, 1 unit

8.6

30.5

L40.5

ICD-10 Finland

Arthropathic psoriasis

5.4

30.5

113

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.7

30.5

770

5227

UJF92

NOMESCO Finland

Capsular endoscopy

4.6

30.2

160

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

3.2

30.2

125

409

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

5.1

29.9

126

L01

ICPC

Neck symptom/complaint

2.0

29.9

378

2069

TNH11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in ankle joint or foot joint

7.9

29.8

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

3.9

29.5

232

J01DB01

ATC

cefalexin; oral

1.9

29.2

1806

15532

M01AB08

ATC

etodolac; oral

2.9

29.2

141

504

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.0

29.1

385

2139

M51.8

ICD-10 Finland

Other specified intervertebral disc disorders

32.2

29.1

R07.4

ICD-10 Finland

Chest pain, unspecified

1.9

28.8

461

2728

NAG62

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, 2-3 vertebraea

104.8

28.7

N06AX16

ATC

venlafaxine; oral

2.0

28.6

343

1841

M54.0

ICD-10 Finland

Panniculitis affecting regions of neck and back

7.4

28.4

L99

ICPC

Musculoskeletal disease other

4.6

28.3

148

H15.1

ICD-10 Finland

Episcleritis

5.0

28.2

125

SAA01

NOMESCO Finland

Simple examination of mouth

1.8

27.6

1686

14279

N06AX11

ATC

mirtazapine; oral

1.7

27.6

687

4618

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

3.5

27.4

293

XA402

NOMESCO Finland

ENMG

6.0

27.3

M02AA10

ATC

ketoprofen; topical

2.1

27.2

273

1369

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.1

27.1

269

1343

S18

ICPC

Laceration/cut

1.7

27.1

840

5975

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

2.2

27.0

240

1147

NB1BG

NOMESCO Finland

Shoulder and humerus MRI examination with high intensity magnet

4.5

27.0

154

E0000UV, ,

ATC

1.6

26.9

921

6715

NA2CG

NOMESCO Finland

Thoracal spine extensive MRI examination with high intensity magnet

9.0

26.9

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.1

26.2

284

1466

J01FA10

ATC

azithromycin; systemic

1.6

25.7

1340

10775

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

6.3

25.7

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.8

25.7

466

2853

SPAT1263

SPAT

Sampling

1.6

25.5

863

6251

J01FF01

ATC

clindamycin; systemic

1.8

25.3

522

3319

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.5

25.2

169

714

ABC26

NOMESCO Finland

Open discectomy of lumbar spine

+∞

25.0

TNG11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in knee

7.2

25.0

A06AC01

ATC

ispaghula (psylla seeds); oral

1.8

25.0

437

2645

D07AC01

ATC

betamethasone; topical

1.6

24.7

717

4989

SPAT1260

SPAT

Consultation of another employee

1.9

24.6

329

1827

L17

ICPC

Foot/toe symptom/complaint

1.7

24.6

586

3872

M51.9

ICD-10 Finland

Intervertebral disc disorder, unspecified

27.9

24.5

M01AB01

ATC

indometacin; systemic, rectal

3.3

24.5

304

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

2.8

24.3

128

479

R20.2

ICD-10 Finland

Paraesthesia of skin

2.5

24.3

164

694

M53.3

ICD-10 Finland

Sacrococcygeal disorders, not elsewhere classified

6.1

24.2

WZA90

NOMESCO Finland

Other medical or dental certificate

1.7

24.2

520

3337

NK6QA

NOMESCO Finland

Measurement of bone density from two or more locations with X-ray

2.7

24.1

137

534

L04AC13

ATC

ixekizumab; parenteral

23.0

23.9

NK5AT

NOMESCO Finland

Joint injection with ultrasound guidance not elsewhere classified

7.2

23.8

WX110

NOMESCO Finland

Infiltration anesthesia

1.7

23.6

1618

13764

J01FA06

ATC

roxithromycin; oral

1.6

23.5

749

5317

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

2.1

23.3

234

1171

Z01.2

ICD-10 Finland

Dental examination

1.6

23.3

1098

8539

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.7

23.2

483

3070

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

2.0

23.0

293

1599

SAA02

NOMESCO Finland

Basic examination of mouth

1.6

23.0

1611

13725

ZX140

NOMESCO Finland

Intra articular

7.7

23.0

R06AE07

ATC

cetirizine; oral

1.6

22.9

992

7559

H04.10

ICD-10 Finland

Dry eye syndrome

2.0

22.8

260

1365

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

3.6

22.7

222

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.4

22.7

168

741

P01AB01

ATC

metronidazole; oral, rectal

1.6

22.7

818

5970

ABC56

NOMESCO Finland

Decompression of lumbar spinal canal and nerve roots

84.3

22.7

R01AD09

ATC

mometasone; nasal

1.6

22.6

1032

7948

NA1BA

NOMESCO Finland

Cervical spine extensive X-ray examination without contrast

20.9

22.6

SPAT1301

SPAT

No procedures

1.7

22.5

554

3679

N02AC04

ATC

dextropropoxyphene; oral

5.5

22.5

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.8

22.3

383

2298

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.4

22.2

167

742

ZYC01

NOMESCO Finland

Remote contact by phone

2.5

21.9

147

620

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.6

21.9

737

5283

M07.4*K50.9

ICD-10 Finland

Arthropathy in Crohn's disease [regional enteritis]

29.4

21.9

SFA10

NOMESCO Finland

One-surface restoration

1.5

21.7

1257

10172

SFA20

NOMESCO Finland

Two-surface restoration

1.6

21.6

1331

10911

J01CA04

ATC

amoxicillin; systemic

1.8

21.6

1857

16518

K07.60

ICD-10 Finland

Snapping jaw

2.4

21.6

150

643

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

3.2

21.6

275

M01AC01

ATC

piroxicam; systemic, rectal

2.2

21.4

194

932

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.6

21.4

1351

11126

K02.1

ICD-10 Finland

Caries of dentine

1.6

21.2

1394

11571

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.5

21.1

1199

9633

M53.2

ICD-10 Finland

Spinal instabilities

50.5

21.1

XCW99

NOMESCO Finland

Other investigative procedure of eye

2.2

21.1

179

838

NG1AE

NOMESCO Finland

Knee joint ultrasound exmination

5.8

21.0

TND11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in joint, wrist or hand

5.8

21.0

L20

ICPC

Joint symptom/complaint NOS

3.0

20.9

328

L40.0

ICD-10 Finland

Psoriasis vulgaris

2.9

20.9

103

372

M35.3

ICD-10 Finland

Polymyalgia rheumatica

4.1

20.9

141

7200A

ICD-9 Finland

Ankylosing spondylitis and other inflammatory spondylopathies, Ankylosing spondylitis

+∞

20.9

AA1AD

NOMESCO Finland

CT of head and brain

1.8

20.8

394

2429

326

Kela drug reimbursment

Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)

4.3

20.7

125

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.2

20.7

186

891

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.6

20.7

601

4149

EB1VA, ,

NOMESCO Finland

1.7

20.6

407

2538

NA7CG

NOMESCO Finland

Spine and spinal cord extensive MRI examination with high intensity magnet

6.6

20.5

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.8

20.5

346

2063

M07.5*K51.9

ICD-10 Finland

Arthropathy in ulcerative colitis

20.3

20.4

ACC51

NOMESCO Finland

Release of median nerve

2.4

20.3

143

617

J45.9

ICD-10 Finland

Asthma, unspecified

1.8

20.2

351

2109

K50.1

ICD-10 Finland

Crohn disease of large intestine

4.9

20.2

R01AD08

ATC

fluticasone; nasal

1.6

20.1

633

4447

TPH04

NOMESCO Finland

Cathetrisation of vein

1.8

20.0

368

2247

K30

ICD-10 Finland

Functional dyspepsia

2.0

20.0

241

1288

SPAT1310

SPAT

Counselling related to known health issue

1.6

20.0

612

4273

H40.5

ICD-10 Finland

Glaucoma secondary to other eye disorders

7.3

19.9

M43.0

ICD-10 Finland

Spondylolysis

21.0

19.9

G54.0

ICD-10 Finland

Brachial plexus disorders

3.9

19.9

151

M76.8

ICD-10 Finland

Other enthesopathies of lower limb, excluding foot

4.8

19.7

M01CB01

ATC

sodium aurothiomalate; parenteral

6.5

19.7

M07.2*L40.5

ICD-10 Finland

Psoriatic spondylitis

29.2

19.6

R52.1

ICD-10 Finland

Chronic intractable pain

16.5

19.6

Z50.1

ICD-10 Finland

Other physical therapy

3.0

19.5

308

Z71.8

ICD-10 Finland

Other specified counselling

1.5

19.5

764

5637

M19.0

ICD-10 Finland

Primary arthrosis of other joints

2.3

19.5

155

706

J20

ICD-10 Finland

Acute bronchitis

2.0

19.4

221

1157

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.5

19.3

1005

7872

WZC00

NOMESCO Finland

Treatment plan or consultation

1.5

19.3

768

5682

K51.3

ICD-10 Finland

Ulcerative (chronic) rectosigmoiditis

3.8

19.3

159

R01AD58

ATC

fluticasone, combinations; nasal

1.6

19.2

639

4539

NH1BG

NOMESCO Finland

Ankle and foot MRI examination with high intensity magnet

4.0

19.2

137

R01AD12

ATC

fluticasone furoate; nasal

1.5

19.2

768

5688

NA3CG, ,

SPAT

5.2

19.1

M06.8

ICD-10 Finland

Other specified rheumatoid arthritis

7.3

19.1

D07AD01

ATC

clobetasol; topical

1.8

19.0

320

1903

A03FA01

ATC

metoclopramide; systemic, rectal

1.7

18.9

413

2642

J01DA01

ATC

[U] cefalexin

1.5

18.9

1232

10089

R01BA52

ATC

pseudoephedrine, combinations; oral

1.6

18.9

543

3726

M13.8

ICD-10 Finland

Other specified arthritis

5.8

18.9

R07.3

ICD-10 Finland

Other chest pain

2.1

18.8

184

911

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

6.8

18.7

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

2.8

18.7

344

M25.2

ICD-10 Finland

Flail joint

5.2

18.6

G55.2*M47.9

ICD-10 Finland

Nerve root and plexus compressions in spondylosis

18.9

18.6

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.7

18.6

372

2323

R09

ICPC

Sinus symptom/complaint

2.0

18.6

216

1138

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.5

18.6

123

516

D07XC01

ATC

betamethasone; topical

2.0

18.6

223

1189

M46

ICD-10 Finland

Other inflammatory spondylopathies

191.6

18.6

R02

ICPC

Shortness of breath/dyspnoea

2.0

18.5

221

1176

XX9XE

NOMESCO Finland

Other ultrasound examination

6.3

18.5

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

18.2

495

3346

L15

ICPC

Knee symptom/complaint

1.6

18.1

465

3098

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

2.4

18.1

131

572

JN3AD

NOMESCO Finland

Abdominal CT examination

2.0

18.1

222

1192

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

18.1

1133

9170

M47.81

ICD-10 Finland

Other spondylosis, occipito-atlanto-axial region

26.9

17.8

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

6.0

17.8

ABC30

NOMESCO Finland

Decompression of cervical nerve roots

+∞

17.7

K51.5

ICD-10 Finland

Left sided colitis

2.9

17.7

298

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

17.6

267

1536

NA3CF

NOMESCO Finland

Lumbar spine extensive MRI examination with median intensity magnet

95.8

17.6

N05CF01

ATC

zopiclone; oral

1.6

17.5

501

3424

AB5CT

NOMESCO Finland

Blockage of nerv root with CT guidance

181.4

17.5

M46.4

ICD-10 Finland

Discitis, unspecified

181.4

17.5

C07AA05

ATC

propranolol; systemic

1.6

17.5

442

2930

NB2AT

NOMESCO Finland

Intra artrial injection of shoulder with ultrasound guidance

5.3

17.5

F01

ICPC

Eye pain

3.0

17.5

267

L08

ICPC

Shoulder symptom/complaint

1.7

17.4

404

2622

L04AC05

ATC

ustekinumab; parenteral

7.4

17.4

R5599

NOMESCO Finland

Other rehabilitation service

3.8

17.4

138

WZC00, ,

SPAT

1.8

17.3

311

1881

R03DC03

ATC

montelukast; oral

1.7

17.2

341

2120

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.6

17.2

377

A02BC04

ATC

rabeprazole; oral

2.1

17.0

179

910

R4110, ,

SPAT

1.9

16.9

209

1125

N03AE01

ATC

clonazepam; systemic

2.6

16.9

100

398

N04BC05

ATC

pramipexole; oral

2.5

16.8

107

441

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.5

16.7

103

418

72510

ICD-8 Finland

Displacement of intervertebral disk, Lumbalis cum prolapsu disci

+∞

16.7

72880

ICD-8 Finland

Vertebrogenic pain syndrome, Radicula syndrome of lower limbs

+∞

16.7

J01FA09

ATC

clarithromycin; systemic

1.5

16.6

624

4527

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.9

16.6

217

1189

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.0

16.6

183

947

RF120, ,

NOMESCO Finland

7.0

16.5

N06AB04

ATC

citalopram; systemic

1.7

16.5

370

2376

J04AB02

ATC

rifampicin; systemic

6.0

16.5

J02AC01

ATC

fluconazole; systemic

1.5

16.5

842

6506

NH3EA

NOMESCO Finland

Feet X-ray examination with load

3.9

16.5

125

R60.0

ICD-10 Finland

Localized oedema

2.0

16.2

178

919

NH1AE

NOMESCO Finland

Ankle joint ultrasound examination

6.8

16.1

K50

ICD-10 Finland

Crohn disease [regional enteritis]

7.1

16.1

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.4

15.8

107

454

K59.1

ICD-10 Finland

Functional diarrhoea

2.3

15.8

122

549

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.7

15.7

311

1931

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

4.6

15.7

L01BB02

ATC

mercaptopurine; oral

3.7

15.7

139

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.2

15.6

130

603

Z3229

NOMESCO Finland

Other healthcare associate professional

2.2

15.6

140

670

AB5BT

NOMESCO Finland

Blockage of nerv root with X-ray guidance

85.7

15.6

M07.3

ICD-10 Finland

Other psoriatic arthropathies

5.1

15.5

M01AE01

ATC

ibuprofen; systemic, rectal

1.9

15.5

1999

18543

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.5

15.5

570

4109

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

2.5

15.5

391

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.8

15.4

256

1512

TNF11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in hip joint

38.3

15.4

C10AC01

ATC

colestyramine; oral

3.3

15.4

180

K51.8

ICD-10 Finland

Other ulcerative colitis

3.9

15.3

118

M01AE51

ATC

ibuprofen, combinations; systemic

7.0

15.3

M79.9

ICD-10 Finland

Soft tissue disorder, unspecified

5.9

15.3

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.8

15.2

248

1456

N05AH04

ATC

quetiapine; oral

1.6

15.2

377

2480

J01MA12

ATC

levofloxacin; systemic

1.8

15.1

267

1605

NA3DG

NOMESCO Finland

Lumbar spine very extensive MRI examination with high intensity magnet

20.2

15.1

A07EA02

ATC

hydrocortisone; rectal

3.4

15.1

162

ZYC05

NOMESCO Finland

Non-real-time text-based remote communication

4.3

15.1

R25.2

ICD-10 Finland

Cramp and spasm

3.6

15.1

138

M41.9

ICD-10 Finland

Scoliosis, unspecified

10.9

15.0

K92.1

ICD-10 Finland

Melaena

2.8

14.9

280

G47.3

ICD-10 Finland

Sleep apnoea

1.6

14.8

379

2513

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.3

14.8

115

519

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

4.9

14.7

X58

ICD-10 Finland

Exposure to other specified factors

1.7

14.7

308

1939

D01

ICPC

Abdominal pain/cramps general

1.7

14.7

277

1695

R03BA01

ATC

beclometasone; inhalant

1.8

14.7

237

1388

A03

ICPC

Fever

1.6

14.6

435

2987

R53

ICD-10 Finland

Malaise and fatigue

1.5

14.6

508

3611

9211

FHL

Exploration or removal of diskusprolapse

+∞

14.6

72870

ICD-8 Finland

Vertebrogenic pain syndrome, Lumbalgia

+∞

14.6

R11

ICD-10 Finland

Nausea and vomiting

2.0

14.6

176

939

H02BX01

ATC

methylprednisolone, combinations; systemic

3.1

14.6

207

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

3.9

14.5

109

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

2.1

14.3

131

631

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.6

14.3

403

2732

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.4

14.3

1279

10860

NG1DA

NOMESCO Finland

X-ray of knees

4.9

14.3

M13.1

ICD-10 Finland

Monoarthritis, not elsewhere classified

4.9

14.3

R05FA02

ATC

opium derivatives and expectorants; systemic

1.5

14.3

723

5540

R03AK07

ATC

formoterol and budesonide; inhalant

1.6

14.2

439

3039

M00.9

ICD-10 Finland

Pyogenic arthritis, unspecified

5.7

14.1

NF2AT

NOMESCO Finland

Injection to hip joint with ultrasound guidance

12.0

14.1

NB1CG

NOMESCO Finland

Shoulder and humerus extensive MRI examination with high intensity magnet

3.9

14.1

107

G43.9

ICD-10 Finland

Migraine, unspecified

1.9

14.0

171

916

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.3

14.0

108

486

WX290

NOMESCO Finland

Other blockage of nerve

1.4

13.9

1152

9628

ABD32

NOMESCO Finland

Implantation of temporary spinal stimulation device

30.2

13.9

R74

ICPC

Upper respiratory infection acute

1.4

13.9

857

6803

M51.2

ICD-10 Finland

Other specified intervertebral disc displacement

53.7

13.8

N05BA04

ATC

oxazepam; oral

1.5

13.8

474

3356

NA7BG

NOMESCO Finland

Spine and spinal cord MRI examination with high intensity magnet

11.5

13.8

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.8

13.8

247

M01AE52

ATC

naproxen and esomeprazole; oral

3.0

13.7

198

J35.0

ICD-10 Finland

Chronic tonsillitis

2.0

13.7

163

865

R06AX27

ATC

desloratadine; oral

1.5

13.7

680

5182

SPAT1104

SPAT

Monitoring of emergency patient

2.3

13.6

103

459

ZXX02

NOMESCO Finland

Extent of procedure, 2 units

4.3

13.6

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

3.1

13.6

178

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.8

13.6

207

1190

A01AB09

ATC

miconazole; local oral

2.1

13.6

139

699

R05

ICPC

Cough

1.5

13.6

487

3478

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

2.5

13.6

336

A07DA03

ATC

loperamide; oral

3.3

13.6

158

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

13.5

857

6823

N05CF02

ATC

zolpidem; oral

1.6

13.5

312

2015

B01AB05

ATC

enoxaparin; parenteral

1.5

13.5

460

3251

M96.1

ICD-10 Finland

Postlaminectomy syndrome, not elsewhere classified

140.8

13.5

G56.2

ICD-10 Finland

Lesion of ulnar nerve

2.9

13.4

217

L04AA11

ATC

[U] etanercept

12.9

13.4

L16

ICPC

Ankle symptom/complaint

1.7

13.3

246

1496

ZXA05

NOMESCO Finland

Left side

1.6

13.3

322

2103

O99.1

ICD-10 Finland

Other diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism complicating pregnancy, childbirth and the puerperium

4.2

13.2

WX002

NOMESCO Finland

Sedation and analgesia

1.7

13.2

280

1767

RF410, ,

NOMESCO Finland

5.8

13.2

X59

ICD-10 Finland

Exposure to unspecified factor

1.6

13.2

351

2344

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

3.8

13.2

103

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.7

13.2

274

1721

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.6

13.1

308

1994

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.9

13.1

175

965

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.9

13.1

158

843

H20.8

ICD-10 Finland

Other iridocyclitis

6.2

12.9

L40.3

ICD-10 Finland

Pustulosis palmaris et plantaris

3.8

12.9

100

K51.2

ICD-10 Finland

Ulcerative (chronic) proctitis

3.3

12.9

148

XCK00

NOMESCO Finland

Perimetry

2.5

12.8

339

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.5

12.8

522

3823

-1, ,

NOMESCO Finland

1.4

12.8

740

5786

A03CA02

ATC

clidinium and psycholeptics; oral

2.6

12.7

275

R51

ICD-10 Finland

Headache

2.0

12.6

140

725

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.7

12.6

233

1417

NBG10

NOMESCO Finland

Acromioplastia

4.7

12.6

L12

ICPC

Hand/finger symptom/complaint

1.6

12.6

342

2294

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

12.5

403

2807

R00.2

ICD-10 Finland

Palpitations

1.9

12.5

176

987

M47.1

ICD-10 Finland

Other spondylosis with myelopathy

+∞

12.5

7245A

ICD-9 Finland

Other and unspecified disorders of back, Backache, unspecified

+∞

12.5

M46.3

ICD-10 Finland

Infection of intervertebral disc (pyogenic)

+∞

12.5

D06

ICPC

Abdominal pain localized other

1.8

12.5

188

1077

298, ,

Kela drug reimbursment

10.1

12.5

NA7EA

NOMESCO Finland

Scoliosis X-ray examination

24.4

12.5

M77.4

ICD-10 Finland

Metatarsalgia

2.0

12.4

135

695

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

3.7

12.4

103

M01AE11

ATC

tiaprofenic acid; oral, rectal

3.2

12.4

157

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.4

12.4

339

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.0

12.4

144

759

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

2.8

12.3

211

G50.1

ICD-10 Finland

Atypical facial pain

3.8

12.3

G57.1

ICD-10 Finland

Meralgia paraesthetica

3.8

12.3

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.6

12.3

350

2373

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.8

12.2

183

1046

UKC02

NOMESCO Finland

Cystoscopy

1.9

12.2

164

906

D82

ICPC

Teeth/gum disease

1.4

12.2

879

7119

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.8

12.2

185

1063

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.8

12.2

171

959

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.9

12.1

163

901

N06AA10

ATC

nortriptyline; systemic

3.7

12.1

100

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.4

12.0

559

4189

S01ED51

ATC

timolol, combinations; ophthalmic

2.3

12.0

394

D02

ICPC

Abdominal pain epigastric

2.0

12.0

127

648

WZC30, ,

SPAT

1.9

11.9

143

761

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.9

11.9

164

914

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.1

11.9

110

533

M03BX01

ATC

baclofen; systemic

3.6

11.9

106

NA6CF

NOMESCO Finland

Sacro-iliac joint extensive MRI examination with median intensity magnet

46.9

11.9

SPAT1097

SPAT

Recording of ECG

1.8

11.9

185

1071

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.1

11.8

119

595

K08.80

ICD-10 Finland

Toothache NOS

1.7

11.8

209

1255

M77.1

ICD-10 Finland

Lateral epicondylitis

1.8

11.7

171

970

JF1DG

NOMESCO Finland

Small bowel very extensive MRI with with high intensity magnet

5.5

11.6

S06.0

ICD-10 Finland

Concussion

1.8

11.6

195

1153

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.7

11.6

212

1284

XQ800

NOMESCO Finland

Prick test

1.8

11.6

171

973

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.3

11.6

387

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

2.9

11.6

185

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.8

11.6

173

989

K51.1

ICD-10 Finland

Ulcerative (chronic) ileocolitis

3.9

11.6

3029

Kela drug reimbursment

Upadacitinib

8.7

11.5

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

3.7

11.5

NA7BT

NOMESCO Finland

Injection to spinal facet joint with radiological guidance

+∞

11.5

M19.2

ICD-10 Finland

Other secondary arthrosis

4.7

11.4

F51.0

ICD-10 Finland

Nonorganic insomnia

1.5

11.4

410

2919

L18

ICPC

Muscle pain

2.3

11.4

365

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

3.9

11.3

M02.8

ICD-10 Finland

Other reactive arthropathies

8.4

11.3

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.0

11.3

129

676

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.9

11.2

132

698

M76.9

ICD-10 Finland

Enthesopathy of lower limb, unspecified

4.4

11.2

ZZH21

NOMESCO Finland

Graft of patients own bone, small pieces

4.5

11.2

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

3.6

11.2

101

JAH01

NOMESCO Finland

Laparoscopy

2.2

11.2

426

D05AX52

ATC

calcipotriol, combinations; topical

2.2

11.1

453

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.7

11.1

229

R06AX22

ATC

ebastine; oral

1.5

11.1

356

2475

R51.81

ICD-10 Finland

Facial pain NOS

2.8

11.0

190

ABD30

NOMESCO Finland

Implantation of spinal stimulation device

13.9

11.0

K51.0

ICD-10 Finland

Ulcerative (chronic) pancolitis

4.5

11.0

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

2.3

11.0

384

S01ED01

ATC

timolol; ophthalmic

3.0

10.9

153

NA6BM

NOMESCO Finland

Sacro-iliac joint MRI examination with 3 Tesla magnet

43.5

10.9

WW200

NOMESCO Finland

Immunization

2.6

10.9

231

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.6

10.9

255

R03AC03

ATC

terbutaline; inhalant

1.6

10.8

256

1658

N20.9

ICD-10 Finland

Urinary calculus, unspecified

3.0

10.8

154

SFA30

NOMESCO Finland

Three-surface restoration

1.4

10.8

785

6333

S43.4

ICD-10 Finland

Sprain and strain of shoulder joint

2.3

10.8

367

UJD02

NOMESCO Finland

Gastroscopy

2.5

10.8

262

R4120

NOMESCO Finland

Occupational therapy

2.0

10.8

109

547

ZXA10

NOMESCO Finland

Bilateral

1.6

10.8

260

1693

R60.9

ICD-10 Finland

Oedema, unspecified

2.3

10.7

368

M08.1

ICD-10 Finland

Juvenile ankylosing spondylitis

28.2

10.7

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.7

10.7

189

1134

SPAT1229

SPAT

Assessment of need for aid

2.3

10.7

362

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

2.3

10.7

343

Z00.0

ICD-10 Finland

General medical examination

1.5

10.6

343

2384

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.4

10.6

468

3462

NAG63

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, more than 3 vertebraea

60.3

10.6

M41.1

ICD-10 Finland

Juvenile idiopathic scoliosis

60.3

10.6

4AB0M, ,

NOMESCO Finland

60.3

10.6

TNF10

NOMESCO Finland

Puncture of hip joint

60.3

10.6

A07AA02

ATC

nystatin; oral

2.3

10.6

357

S01EC01

ATC

acetazolamide; systemic

3.2

10.6

125

RF420, ,

NOMESCO Finland

4.8

10.5

256, ,

Kela drug reimbursment

14.3

10.5

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

3.0

10.5

157

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

2.0

10.5

109

553

L40.9

ICD-10 Finland

Psoriasis, unspecified

3.4

10.4

106

N83.1

ICD-10 Finland

Corpus luteum cyst

3.4

10.4

106

M48.1

ICD-10 Finland

Ankylosing hyperostosis [Forestier]

110.5

10.4

ZXA00

NOMESCO Finland

Right side

1.5

10.4

334

2321

N06AX12

ATC

bupropion; oral

1.7

10.3

187

1130

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

3.5

10.3

102

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

2.3

10.3

349

M75.8

ICD-10 Finland

Other shoulder lesions

2.3

10.3

362

NH1CG

NOMESCO Finland

Ankle and foot extensive MRI examination with high intensity magnet

3.7

10.3

SPAT1210

SPAT

Application of cast or individual aid

2.4

10.2

287

A03FA02

ATC

cisapride; oral, rectal

2.1

10.2

435

R1250

NOMESCO Finland

Evaluation of functional capability

3.1

10.2

138

M75.5

ICD-10 Finland

Bursitis of shoulder

3.0

10.2

154

J01CE02

ATC

phenoxymethylpenicillin; oral

1.4

10.2

1487

13297

TQW40, ,

SPAT

1.8

10.2

168

989

NA3AA, ,

SPAT

2.4

10.2

288

R03BA05

ATC

fluticasone; inhalant

1.5

10.2

338

2364

J01DA09

ATC

[U] cefadroxil

1.4

10.1

492

3702

R21

ICPC

Throat symptom/complaint

1.4

10.1

550

4221

SPAT1325

SPAT

Vaccination

1.4

10.1

509

3854

C07AB07

ATC

bisoprolol; oral

1.4

10.1

581

4502

M17.5

ICD-10 Finland

Other secondary gonarthrosis

4.0

10.0

RF421, ,

NOMESCO Finland

14.6

10.0

M76.6

ICD-10 Finland

Achilles tendinitis

2.3

10.0

341

J01FA01

ATC

erythromycin; systemic

1.5

10.0

317

2196

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.1

9.9

427

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

2.0

9.9

110

571

A02BA04

ATC

nizatidine; systemic

2.2

9.9

368

SPAT1312

SPAT

General health counselling

1.4

9.9

612

4797

G03DB01

ATC

dydrogesterone; oral

1.6

9.9

262

1743

J31.0

ICD-10 Finland

Chronic rhinitis

1.7

9.9

171

1021

NF1DA

NOMESCO Finland

X-ray of hips

3.9

9.9

OAB93, ,

SPAT

1.7

9.8

188

1153

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

2.3

9.8

305

R10.0

ICD-10 Finland

Acute abdomen

2.4

9.8

268

G55.1*M51.9

ICD-10 Finland

Nerve root and plexus compressions in intervertebral disc disorders (M50-M51+)

26.1

9.8

J01EA01

ATC

trimethoprim; systemic

1.4

9.8

437

3235

WW200, ,

SPAT

1.4

9.8

502

3810

G55.1

ICD-10 Finland

Nerve root and plexus compressions in intervertebral disc disorders

20.1

9.8

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.5

9.8

314

2179

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.2

9.8

370

D64.9

ICD-10 Finland

Anaemia, unspecified

1.9

9.8

121

652

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

2.8

9.8

169

M24.8

ICD-10 Finland

Other specific joint derangements, not elsewhere classified

4.7

9.8

SPAT1283

SPAT

Restricted health certificate

1.4

9.7

471

3538

A05

ICPC

Feeling ill

1.8

9.7

149

858

TQW80

NOMESCO Finland

Local dermatologic skincare

2.8

9.7

175

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.4

9.7

762

6197

M01AB16

ATC

aceclofenac; oral

3.0

9.7

137

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.7

9.7

175

1057

R10.2

ICD-10 Finland

Pelvic and perineal pain

2.5

9.6

228

M22.4

ICD-10 Finland

Chondromalacia patellae

2.3

9.6

308

C03CA01

ATC

furosemide; systemic

1.6

9.6

248

1639

D11

ICPC

Diarrhoea

1.5

9.6

272

1836

NF1BA

NOMESCO Finland

Hip extensive X-ray examination

3.0

9.6

138

TNX32

NOMESCO Finland

Custom moulded splint, unspecified region

2.1

9.6

413

H53.1

ICD-10 Finland

Subjective visual disturbances

1.9

9.6

130

722

SPAT1216

SPAT

Assessment of functional ability

1.7

9.5

164

977

M05BA04

ATC

alendronic acid; oral

2.1

9.5

461

M01AX05

ATC

glucosamine; oral

1.7

9.5

172

1039

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.5

9.5

276

1874

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.7

9.5

165

986

C01CA24

ATC

epinephrine; parenteral

1.8

9.5

145

835

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.9

9.5

126

695

R04.0

ICD-10 Finland

Epistaxis

2.0

9.4

483

N06AB10

ATC

escitalopram; oral

1.4

9.4

455

3415

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.6

9.4

242

1598

O47.0

ICD-10 Finland

False labour before 37 completed weeks of gestation

1.6

9.4

230

1501

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.3

9.4

286

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.7

9.4

165

989

M01AC02

ATC

tenoxicam; systemic, rectal

2.6

9.4

196

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.8

9.3

150

877

H81.0

ICD-10 Finland

Ménière disease

3.2

9.3

109

C09CA06

ATC

candesartan; oral

1.4

9.3

384

2801

M02.1

ICD-10 Finland

Postdysenteric arthropathy

10.7

9.3

G03DC02

ATC

norethisterone; oral

1.7

9.2

156

925

F29

ICPC

Eye symptom/complaint other

1.6

9.2

198

1252

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

1.7

9.2

157

934

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

1.8

9.1

144

837

Z3231

NOMESCO Finland

Registered nurse

1.4

9.1

425

3168

J45

ICD-10 Finland

Asthma

1.6

9.1

191

1200

G04BD08

ATC

solifenacin; oral

2.2

9.1

322

D07AC13

ATC

mometasone; topical

1.4

9.1

508

3908

I84.1

ICD-10 Finland

Internal hemorrhoids with other complications

3.1

9.1

116

Z35.8

ICD-10 Finland

Supervision of other high-risk pregnancies

1.6

9.1

231

1522

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.8

9.1

138

794

M16.1

ICD-10 Finland

Other primary coxarthrosis

1.9

9.0

115

626

OAA65, ,

SPAT

1.4

9.0

537

4173

TNB11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in shoulder joint

9.1

9.0

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.5

9.0

212

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.4

9.0

469

3566

R12

ICD-10 Finland

Heartburn

1.7

9.0

161

971

N05BA01

ATC

diazepam; systemic, rectal

1.6

9.0

187

1174

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.4

9.0

429

3213

R03AC13

ATC

formoterol; inhalant

2.2

8.9

338

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

2.1

8.9

425

M05BA07

ATC

risedronic acid; oral

3.5

8.8

SDA04

NOMESCO Finland

Demanding periodontal treatment

1.3

8.8

636

5093

H30.2

ICD-10 Finland

Posterior cyclitis

8.6

8.8

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.8

8.8

125

705

NG1CG

NOMESCO Finland

Knee and lower leg extensive MRI examination with high intensity magnet

2.5

8.7

221

H26.3

ICD-10 Finland

Drug-induced cataract

7.2

8.7

SDA01

NOMESCO Finland

Periodontal treatment, very brief

1.4

8.7

602

4785

SGA01

NOMESCO Finland

Emergency treatment

1.4

8.7

364

2658

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.6

8.7

188

1190

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

2.0

8.7

477

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

3.9

8.7

R05FB02

ATC

cough suppressants and expectorants; systemic

1.4

8.7

542

4241

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.3

8.7

631

5057

SPAT1240

SPAT

Therapeutic discussion

1.5

8.6

246

1663

R52.0

ICD-10 Finland

Acute pain

2.2

8.6

317

K59.09

ICD-10 Finland

Constipation, unspecified

2.1

8.6

390

N89

ICPC

Migraine

1.9

8.6

105

564

G72.9

ICD-10 Finland

Myopathy, unspecified

8.2

8.6

SPAT1211

SPAT

Application of soft bandage

1.8

8.6

131

755

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

2.9

8.5

142

RF210, ,

NOMESCO Finland

2.6

8.5

176

C08CA05

ATC

nifedipine; systemic

2.1

8.5

351

XKD00

NOMESCO Finland

Uroflowmetry

1.8

8.5

121

682

L04

ICPC

Chest symptom/complaint

1.9

8.5

113

624

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.7

8.5

171

1064

M41.2

ICD-10 Finland

Other idiopathic scoliosis

27.6

8.5

M07.4

ICD-10 Finland

Arthropathy in Crohn disease [regional enteritis]

27.6

8.5

M50.8

ICD-10 Finland

Other cervical disc disorders

27.6

8.5

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

2.0

8.4

448

G55.2

ICD-10 Finland

Nerve root and plexus compressions in spondylosis

90.4

8.4

NGF35

NOMESCO Finland

Plastic operation of joint cartilage of knee

2.5

8.4

213

S01BC03

ATC

diclofenac; ophthalmic

2.9

8.4

138

S01EA05

ATC

brimonidine; ophthalmic

3.5

8.4

NA6AG, ,

NOMESCO Finland

+∞

8.3

NAG66

NOMESCO Finland

Posterior interbody fusion of lumbar spine, 2 vertebrae

+∞

8.3

71240

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Spondylitis ankylopoietica

+∞

8.3

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.4

8.3

233

RK220, ,

NOMESCO Finland

9.5

8.3

N05BA12

ATC

alprazolam; oral

1.7

8.3

156

954

L11

ICPC

Wrist symptom/complaint

1.6

8.3

194

1254

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.2

8.2

336

A29

ICPC

General symptom/complaint other

1.6

8.2

201

1311

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.7

8.2

146

878

E66.01

ICD-10 Finland

Obesity due to excess calories

1.6

8.2

207

1360

M77.9

ICD-10 Finland

Enthesopathy, unspecified

2.2

8.2

304

R00.0

ICD-10 Finland

Tachycardia, unspecified

2.0

8.2

418

H02AB09

ATC

hydrocortisone; systemic

2.6

8.2

180

A04AA01

ATC

ondansetron; systemic, rectal

1.8

8.2

130

758

NHG80

NOMESCO Finland

Fusion of first tarsometatarsal joint

2.6

8.2

186

R31

ICD-10 Finland

Unspecified haematuria

1.9

8.2

105

574

NH3CG

NOMESCO Finland

Extensive MRI of foot

4.4

8.1

R2110

NOMESCO Finland

Giving the first information

1.7

8.1

137

813

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.6

8.1

182

1164

H22.1

ICD-10 Finland

Iridocyclitis in other diseases classified elsewhere

33.5

8.1

NB1BG, ,

SPAT

2.3

8.1

261

N03AX09

ATC

lamotrigine; oral

1.8

8.0

109

606

TAB20

NOMESCO Finland

Epidural puncture

10.1

8.0

C05AA08

ATC

fluocortolone; rectal, topical

1.6

8.0

190

1231

L04AC21

ATC

bimekizumab; systemic

22.1

8.0

U07

ICPC

Urine symptom/complaint other

1.8

8.0

121

696

XQ802

NOMESCO Finland

Epicutan test

2.0

8.0

464

M20.1

ICD-10 Finland

Hallux valgus (acquired)

1.8

8.0

113

637

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.8

8.0

113

637

M76.0

ICD-10 Finland

Gluteal tendinitis

3.2

8.0

K04.09

ICD-10 Finland

Pulpit UNS

1.8

8.0

109

608

M13.0

ICD-10 Finland

Polyarthritis, unspecified

3.4

7.9

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

1.7

7.9

158

980

R13

ICD-10 Finland

Dysphagia

1.9

7.9

486

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.7

7.9

135

803

XFP96

NOMESCO Finland

Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation

3.7

7.9

A06AD11

ATC

lactulose; oral

1.7

7.9

149

912

M06.4

ICD-10 Finland

Inflammatory polyarthropathy

7.8

7.9

ND1BG

NOMESCO Finland

Wrist and hand MRI examination with high intensity magnet

2.9

7.9

121

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.6

7.9

191

1245

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

1.9

7.8

481

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

10.8

7.8

M19.8

ICD-10 Finland

Other specified arthrosis

2.4

7.8

215

C08CA01

ATC

amlodipine; oral

1.4

7.8

418

3187

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.0

7.8

385

EMB10

NOMESCO Finland

Tonsillectomy

1.7

7.7

155

963

-50

ICPC

Medication/prescr/renewal

2.3

7.7

266

M85.3

ICD-10 Finland

Osteitis condensans

45.1

7.7

M07.5

ICD-10 Finland

Arthropathy in ulcerative colitis

45.1

7.7

R07.0

ICD-10 Finland

Pain in throat

1.6

7.7

165

1043

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.9

7.7

491

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

1.9

7.7

542

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

3.3

7.7

N06AX26

ATC

vortioxetine; oral

1.6

7.6

173

1109

N06AX03

ATC

mianserin; oral

2.2

7.6

287

K29.1

ICD-10 Finland

Other acute gastritis

4.0

7.6

D07AB08

ATC

desonide; topical

1.6

7.6

199

1320

J05AB01

ATC

aciclovir; systemic

1.4

7.6

388

2932

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.4

7.6

485

3800

E27.4

ICD-10 Finland

Other and unspecified adrenocortical insufficiency

11.9

7.6

WX320

NOMESCO Finland

Spinalanesthesy

1.4

7.5

362

2706

TAW99

NOMESCO Finland

Other minor neurosurgical procedure

8.9

7.5

XPX04

NOMESCO Finland

Angioscopy

8.9

7.5

ZYC01, ,

SPAT

1.5

7.5

229

1569

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.7

7.5

143

877

N30.0

ICD-10 Finland

Acute cystitis

1.4

7.5

304

2204

J05AB11

ATC

valaciclovir; oral

1.5

7.5

252

1762

J01MA06

ATC

norfloxacin; oral

1.6

7.5

192

1268

F43.1

ICD-10 Finland

Post-traumatic stress disorder

2.1

7.5

343

OAA81, ,

SPAT

1.9

7.5

540

G04BD04

ATC

oxybutynin; oral, transdermal

2.2

7.4

290

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

7.4

571

4594

B01AB10

ATC

tinzaparin; parenteral

1.6

7.4

159

1005

F45.8

ICD-10 Finland

Other somatoform disorders

1.6

7.4

165

1053

TNE11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in sacroiliac joint

80.4

7.4

R01AD11

ATC

triamcinolone; nasal

1.6

7.4

151

943

KH1AD

NOMESCO Finland

CT of urinary organs

2.4

7.4

214

J34.2

ICD-10 Finland

Deviated nasal septum

1.9

7.4

491

N06AB03

ATC

fluoxetine; oral

1.5

7.4

205

1378

G04BD12

ATC

mirabegron; oral

1.7

7.4

123

728

Y89.9

ICD-10 Finland

Sequelae of unspecified external cause

3.8

7.4

SFD11

NOMESCO Finland

Gradual caries removal, at least two tooth surfaces

2.0

7.3

359

G44.8

ICD-10 Finland

Other specified headache syndromes

2.7

7.3

143

K80

ICPC

Cardiac arrhythmia NOS

1.7

7.3

119

699

L02.3

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of buttock

2.3

7.3

234

NA6DG

NOMESCO Finland

Sacro-iliac joint very extensive MRI examination with high intensity magnet

+∞

7.3

L29

ICPC

Musculoskeletal sympt/complt other

1.7

7.3

136

831

63497

ICD-8 Finland

Other complications of pregnancy, Partus prematurus imminens, alibi non classificabilis

3.2

7.2

KMAK, ,

NOMESCO Finland

1.3

7.2

1085

9522

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.5

7.2

242

1692

OAB42, ,

SPAT

1.5

7.1

251

1771

M48.9

ICD-10 Finland

Spondylopathy, unspecified

30.1

7.1

NA6CG, ,

SPAT

30.1

7.1

NA3SA

NOMESCO Finland

Lumbar spine X-ray examination in standing position

20.1

7.1

A06AC51

ATC

ispaghula, combinations; oral

2.0

7.1

356

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.8

7.1

128

WX702

NOMESCO Finland

Supraglottic ventilation device

1.8

7.1

541

R35

ICD-10 Finland

Polyuria

2.0

7.1

391

WX704

NOMESCO Finland

Intubation

1.7

7.1

123

736

H01

ICPC

Ear pain/earache

1.5

7.1

244

1715

F43.21

ICD-10 Finland

Adaptation disorder with prolonged depression

3.8

7.1

TAC99

NOMESCO Finland

Other blockade for chronic pain

8.8

7.0

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.9

7.0

456

NH3AE

NOMESCO Finland

Feet ultrasound examination

10.1

7.0

W19

ICD-10 Finland

Unspecified fall

1.6

7.0

144

901

J01CA08

ATC

pivmecillinam; oral

1.3

7.0

805

6826

SPAT1254

SPAT

Administration of medicine

1.5

7.0

205

1394

ZY010, ,

SPAT

3.2

7.0

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

1.9

7.0

450

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

3.2

7.0

SPAT1255

SPAT

Intravenous administration of medicine

1.9

7.0

479

S29

ICPC

Skin symptom/complaint other

1.4

7.0

333

2486

NBA30

NOMESCO Finland

Exploration of joint of shoulder or upper arm, arthroscopic

3.0

7.0

102

J01FA15

ATC

telithromycin; oral

1.6

7.0

156

998

78559

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD

2.6

6.9

153

J01.1

ICD-10 Finland

Acute frontal sinusitis

2.6

6.9

153

SPAT1058

SPAT

PEF monitoring instruction

1.8

6.9

109

635

SFA00

NOMESCO Finland

Small restoration

1.5

6.9

256

1825

L04AF03

ATC

upadacitinib; oral

5.8

6.9

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

2.2

6.9

253

B02AA02

ATC

tranexamic acid; systemic

1.4

6.9

279

2022

35399

ICD-8 Finland

Sciatica

13.8

6.9

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.8

6.9

109

636

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.6

6.9

140

875

R01AD59

ATC

mometasone, combinations; nasal

1.6

6.9

171

1122

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

6.8

539

4346

TEW99

NOMESCO Finland

Other minor procedure in surgery of teeth, jaws, mouth and pharynx

1.9

6.8

461

NJ3NA

NOMESCO Finland

Measurement of difference in extremity lengty with X-ray

4.1

6.8

NG1EA

NOMESCO Finland

Knee X-ray examination with wrench

3.8

6.8

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.5

6.8

201

1369

L04AD01

ATC

ciclosporin; systemic

2.8

6.8

120

G99.2*M51.0

ICD-10 Finland

Lumbar and other intervertebral disc disorders with myelopathy

40.2

6.8

NA3BA

NOMESCO Finland

Lumbar spine extensive X-ray examination without contrast

40.2

6.8

NA3CM

NOMESCO Finland

Lumbar spine extensive MRI examination with 3 Tesla magnet

40.2

6.8

XQ801

NOMESCO Finland

Intracutantest

4.3

6.7

L87

ICPC

Bursitis/tendinitis/synovitis NOS

3.1

6.7

G04CA02

ATC

tamsulosin; oral

1.6

6.7

151

966

N01

ICPC

Headache

1.4

6.7

258

1851

R03BA02

ATC

budesonide; inhalant

1.4

6.7

310

2299

E000001, ,

ATC

1.4

6.7

371

2835

NBL22

NOMESCO Finland

Myotomy, tenotomy or excision of tendon of upper arm

3.9

6.7

R83

ICPC

Respiratory infection other

1.3

6.7

635

5247

H15.0

ICD-10 Finland

Scleritis

7.2

6.7

I73.0

ICD-10 Finland

Raynaud syndrome

2.5

6.7

162

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

1.6

6.7

163

1064

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.4

6.7

388

2990

F20.9

ICD-10 Finland

Schizophrenia, unspecified

0.1

6.7

269

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

1.8

6.7

479

N02CC03

ATC

zolmitriptan; nasal, oral

1.7

6.7

120

726

N81.6

ICD-10 Finland

Rectocele

1.8

6.7

501

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.6

6.7

172

1138

D05AX02

ATC

calcipotriol; topical

2.2

6.7

244

XCH00

NOMESCO Finland

Eye pressure measurement

2.1

6.6

304

G03CA04

ATC

estriol; systemic, vaginal

2.2

6.6

264

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.2

6.6

251

L04AK01

ATC

leflunomide; oral

5.5

6.6

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.6

6.6

133

829

D94

ICPC

Chronic enteritis/ulcerative colitis

3.6

6.6

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

1.9

6.6

388

R75

ICPC

Sinusitis acute/chronic

1.8

6.6

100

577

ACC53

NOMESCO Finland

Release of ulnar nerve

3.4

6.6

CHD65

NOMESCO Finland

Nonpenetrating glaucoma surgery

8.7

6.5

M19.9

ICD-10 Finland

Arthrosis, unspecified

2.2

6.5

259

A02BX02

ATC

sucralfate; oral

2.4

6.5

170

H40.4

ICD-10 Finland

Glaucoma secondary to eye inflammation

10.0

6.5

W22

ICD-10 Finland

Striking against or struck by other object(s)

1.7

6.5

120

731

R03AC12

ATC

salmeterol; inhalant

2.2

6.5

253

Z30.2

ICD-10 Finland

Sterilization

1.5

6.5

197

1350

J30.4

ICD-10 Finland

Allergic rhinitis, unspecified

1.8

6.5

528

M53.9

ICD-10 Finland

Dorsopathy, unspecified

6.2

6.5

M51

ICD-10 Finland

Other intervertebral disc disorders

6.2

6.5

SPAT1360

SPAT

Extensive global examination

1.8

6.4

478

K03.64

ICD-10 Finland

Dental calculus supragingival

1.3

6.4

740

6263

TAB00

NOMESCO Finland

Lumbar puncture

1.9

6.4

378

M25.4

ICD-10 Finland

Effusion of joint

3.0

6.4

J46

ICD-10 Finland

Status asthmaticus

2.4

6.4

166

TAB22

NOMESCO Finland

Stoppin epidural fluid escape with coagulated blood

2.9

6.4

102

D19

ICPC

Teeth/gum symptom/complaint

1.3

6.3

644

5362

N07CA01

ATC

betahistine; oral

1.8

6.3

465

D07AB02

ATC

hydrocortisone butyrate; topical

1.3

6.3

528

4284

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.1

6.3

296

RK210, ,

NOMESCO Finland

8.2

6.3

I20.09

ICD-10 Finland

Unstable angina

2.4

6.3

179

M50.9

ICD-10 Finland

Cervical disc disorder, unspecified

11.0

6.3

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.4

6.3

234

1670

XF402

NOMESCO Finland

ECG with work load test

1.7

6.3

103

608

ABC10

NOMESCO Finland

Microsurgical excision of cervical intervertebral disc displacement

+∞

6.3

G99.2*M47.1

ICD-10 Finland

Spondylogenic compression of spinal cord

+∞

6.3

7221A

ICD-9 Finland

Intervertebral disk disorders, Displacement of thoracic or lumbar intervertebral disk without myelopathy

+∞

6.3

71700, ,

ICD-8 Finland

+∞

6.3

M47.8

ICD-10 Finland

Other spondylosis

+∞

6.3

R63.4

ICD-10 Finland

Abnormal weight loss

2.2

6.2

244

J45.1

ICD-10 Finland

Nonallergic asthma

1.7

6.2

101

595

P02

ICPC

Acute stress reaction

1.6

6.2

144

930

J01.9

ICD-10 Finland

Acute sinusitis, unspecified

1.8

6.2

543

S01XA18

ATC

ciclosporin; ophthalmic

4.0

6.2

R05

ICD-10 Finland

Cough

1.4

6.1

365

2820

R78

ICPC

Acute bronchitis/bronchiolitis

2.6

6.1

127

C09CA01

ATC

losartan; oral

1.4

6.1

293

2187

N06AX22

ATC

agomelatine; oral

2.2

6.1

240

N05CD07

ATC

temazepam; oral

1.7

6.1

105

629

P72

ICPC

Schizophrenia

0.2

6.0

251

SPAT1098

SPAT

Exercise ECG

3.1

6.0

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

1.8

6.0

458

UJF12

NOMESCO Finland

Enteroscopy through intestinal stoma

10.0

6.0

TCC40

NOMESCO Finland

Closure of lacrimal canaliculus with plug

10.0

6.0

SPAT1266

SPAT

Separate instruction to prepare for procedure

2.3

6.0

183

H11.3

ICD-10 Finland

Conjunctival haemorrhage

2.0

6.0

295

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

3.2

6.0

XF400

NOMESCO Finland

ECG with 12 standard connections

1.5

6.0

169

1140

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3006315) Basophils [#/volume] in Blood

1827

9035

7.02

310.54

11.0

6.3

0.04

e9/l

2.84

1732

7901

(3001604) Monocytes [#/volume] in Blood

1826

9030

7.00

310.23

11.0

6.3

0.55

e9/l

0.65

1732

7898

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

572

636

11.80

307.65

1.6

0.04

0.19

iu/ml

0.76

104

(3008898) HLA-B27 [Presence]

713

697

14.65

307.65

1.1

—

(3013115) Eosinophils [#/volume] in Blood

1848

9353

7.08

301.84

11.2

6.6

0.18

e9/l

1.03

1768

8319

(3019198) Lymphocytes [#/volume] in Blood

1836

9309

6.86

297.06

11.1

6.3

2.09

1.96

e9/l

2.94

1758

8343

(3013650) Neutrophils [#/volume] in Blood by Automated count

1877

10105

6.83

270.69

13.1

9.7

3.76

3.96

e9/l

5.84

1785

8842

(3037522) Nuclear Ab [Titer] in Serum

848

2604

4.67

254.47

1.5

1.4

414.30

546.51

titre

1.48

179

525

(3019069) Monocytes/Leukocytes in Blood

1631

8311

4.72

238.41

11.1

6.5

8.51

8.50

0.07

1594

7875

(3006504) Eosinophils/Leukocytes in Blood

1624

8295

4.65

235.39

11.0

6.4

2.69

2.77

0.83

1586

7849

(3022096) Basophils/Leukocytes in Blood

1621

8286

4.63

234.24

11.2

6.5

0.74

0.68

5.28

1584

7824

(3018010) Neutrophils/Leukocytes in Blood

1641

8519

4.64

230.60

10.8

6.2

54.93

56.49

8.25

1610

8209

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

2051

12727

9.97

229.74

9.5

3.6

9.94

9.60

mm/h

0.71

2005

12004

(3002030) Lymphocytes/Leukocytes in Blood

1641

8682

4.50

220.29

11.0

6.3

31.29

29.28

15.10

1612

8306

(3023420) DNA double strand Ab [Units/volume] in Serum

384

744

6.04

194.42

1.5

2.1

6.37

7.88

iu/ml

0.35

175

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1985

12691

6.75

193.83

11.7

7.3

71.48

75.35

u/l

3.78

1947

12070

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

137

20.22

176.63

1.7

2.6

8.45

10.45

mg/l

2.40

111

(3035350) Ketones [Presence] in Urine by Test strip

1605

9426

3.60

159.93

5.3

3.2

3.46

6.39

estimate

0.32

338

1996

(3021601) Nitrite [Presence] in Urine by Test strip

1595

9350

3.56

158.99

5.2

3.2

0.00

estimate

0.50

339

1986

(3009261) Glucose [Presence] in Urine by Test strip

1605

9489

3.55

156.78

5.3

3.2

0.00

0.01

estimate

2.04

333

1903

(3015736) pH of Urine

1364

7527

3.14

145.48

4.5

2.9

6.24

6.21

0.41

752

4365

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

108

20.23

139.79

1.4

1.8

183.51

78.36

au/ml

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

738

2958

3.25

136.74

1.4

1.3

12.29

10.45

u/ml

0.28

309

1262

(3017732) Neutrophils [#/volume] in Blood

596

2144

3.44

131.24

3.0

3.2

4.01

4.31

e9/l

1.12

536

1935

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

765

3300

3.02

122.64

1.4

1.3

31.39

23.84

iu/ml

0.39

218

951

(3017143) Hepatitis C virus Ab [Presence] in Serum

726

3117

2.98

116.44

1.5

1.7

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

48.57

113.18

1.7

1.4

—

(40760892) CBC W Ordered Manual Differential panel - Blood

922

4644

2.70

107.27

6.9

4.2

—

(3048689) Calprotectin [Mass/mass] in Stool

642

2693

2.95

106.02

3.7

2.7

163.02

108.13

ug/g

2.47

552

2177

(3021879) Hepatitis B virus core Ab [Presence] in Serum

551

2136

3.11

104.58

1.4

1.5

—

(3045414) Leukocytes [Presence] in Urine

424

1408

3.49

103.88

2.1

1.9

0.00

0.02

estimate

1.06

336

(3029937) Albumin [Presence] in Urine by Test strip

949

4919

2.63

103.24

5.7

3.2

0.00

estimate

1.54

330

1889

(40761535) Cells panel - Urine sediment

314

887

3.96

97.52

4.3

3.0

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1289

8055

2.45

89.67

3.0

2.4

74.65

73.81

nmol/l

0.56

1231

7563

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

11.37

88.91

2.9

3.7

7.79

9.35

mg/l

0.92

(3002179) Metamyelocytes/Leukocytes in Blood

391

1368

3.26

87.04

5.1

4.6

0.47

0.59

0.40

102

370

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

11.89

83.89

2.6

2.7

25.00

50.33

au/ml

1.08

(3025159) Blasts/Leukocytes in Blood

392

1406

3.18

83.48

6.2

5.1

0.04

0.40

0.77

311

(3017181) Myelocytes/Leukocytes in Blood

396

1429

3.16

83.47

5.6

4.8

0.48

0.94

3.09

103

386

(3045424) Erythrocytes [Presence] in Urine

269

764

3.87

82.37

2.1

1.9

0.00

0.02

estimate

1.08

256

(3021440) Promyelocytes/Leukocytes in Blood

384

1376

3.17

81.80

5.7

4.9

0.04

0.10

1.02

333

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1172

7242

2.32

80.50

5.2

3.0

0.00

0.08

estimate

0.78

305

1645

(3019150) Specific gravity of Urine by Refractometry

753

3969

2.36

73.58

5.8

3.2

1.02

1.41

kg/l

0.50

529

2553

(3015171) Extractable nuclear Ab [Units/volume] in Serum

236

687

3.73

69.36

1.3

1.2

1.66

0.83

u/ml

0.26

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

888

5154

2.21

67.63

1.7

1.8

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

1054

6567

2.16

66.79

5.1

4.7

37.25

36.85

g/l

1.61

998

6225

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2148

18531

7.61

63.69

21.5

11.0

14.34

21.76

mg/l

40.41

1951

14639

(3021589) Normoblasts [#/volume] in Blood

1222

8159

2.12

63.48

14.4

9.6

0.00

e9/l

0.29

1090

6692

(3018095) Leukocytes [#/volume] in Urine

967

5968

2.11

61.28

4.2

3.4

34.16

94.01

e6/l

4.56

650

3857

(40758558) Short blood count panel - Blood

848

5034

2.11

59.03

7.4

6.0

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

716

4057

2.13

55.67

2.2

2.0

134.02

219.57

u/l

2.58

689

3867

(3014051) Protein [Presence] in Urine by Test strip

882

5432

2.04

54.52

3.3

2.5

0.00

0.05

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

137

323

4.46

53.49

1.6

1.4

—

(3000475) Leukocytes [#/volume] in Synovial fluid

132

304

4.56

53.08

1.9

1.6

8908.25

15919.79

e6/l

0.88

102

208

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1067

7132

1.96

51.25

6.0

6.5

1.22

1.21

mmol/l

1.56

936

6188

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

299

1201

2.72

50.37

2.5

2.4

17.84

21.06

au/ml

0.32

183

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

283

1119

2.75

49.09

1.3

51.55

51.26

au/ml

0.01

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

953

6234

1.93

47.79

5.4

5.9

1.22

1.21

mmol/l

0.71

901

5816

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

707

4196

2.01

46.96

2.6

2.1

2.58

2.66

mg/l

0.52

647

3650

(3005719) IgG [Mass/volume] in Serum or Plasma

311

1333

2.55

45.73

2.4

2.9

10.73

10.69

g/l

0.08

300

1246

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1161

8214

1.87

44.70

5.4

6.1

9.39

10.91

umol/l

9.64

1096

7823

(3022145) Colonoscopy Study observation

380

1810

2.33

44.18

1.5

1.4

—

(3000850) Epithelial cells [#/volume] in Urine

565

3166

2.06

43.51

2.7

2.5

4.83

7.75

e6/l

6.83

529

2864

(3031040) Bacteria [#/volume] in Urine by Automated count

1473

11319

1.91

42.98

5.0

3.7

115.45

1643.25

e6/l

1.88

143

(3002582) Erythrocytes [#/volume] in Urine

765

4787

1.92

42.68

3.4

2.8

18.97

78.31

e6/l

2.70

620

3515

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

776

4892

1.91

42.23

3.0

2.5

54.52

60.14

u/l

2.55

734

4583

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

2024

17588

2.88

42.06

15.5

10.3

94.13

91.49

ml/min/173m2

7.90

1907

15842

(3006571) Granulocytes/Leukocytes in Synovial fluid

121

6.03

40.04

1.6

1.7

52.16

53.83

0.10

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

457

2438

2.10

39.75

2.7

2.4

0.87

1.26

e6/l

0.90

302

1179

(3030467) Casts [#/volume] in Urine by Automated count

666

4101

1.89

38.20

3.1

2.7

0.23

0.37

e6/l

1.49

517

2868

(3020564) Creatinine [Moles/volume] in Serum or Plasma

2163

19747

6.52

37.97

22.7

13.1

70.57

71.40

umol/l

0.84

2154

19511

(3030981) Hyaline casts [#/volume] in Urine by Automated count

253

1075

2.53

37.56

2.2

2.3

0.21

0.41

e6/l

1.32

235

1024

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

782

5114

1.82

36.71

3.5

2.7

138.49

39.73

ng/l

0.41

410

2658

(3044941) Cell count panel - Synovial fluid

233

4.26

36.03

1.6

1.4

—

(3028026) IgM [Mass/volume] in Serum or Plasma

245

1056

2.49

35.20

1.6

1.9

1.26

1.41

g/l

1.19

239

994

(3026493) Urate [Moles/volume] in Serum or Plasma

638

3983

1.85

34.41

2.2

2.4

312.41

325.51

umol/l

3.10

562

3678

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2155

19813

5.19

33.17

20.5

9.4

26.52

26.41

u/l

0.09

2139

19359

(3007164) IgA [Mass/volume] in Serum or Plasma

663

4266

1.79

31.95

1.5

2.39

2.22

g/l

1.49

475

2866

(3018418) pH of Serum or Plasma

651

4167

1.80

31.92

3.5

3.8

7.39

7.40

0.43

456

2899

(3003329) Lymphocytes/Leukocytes in Synovial fluid

6.29

31.38

1.6

1.5

38.70

35.68

0.18

(3041096) Erythrocytes [Presence] in Urine by Automated

821

5641

1.73

31.29

3.8

2.6

0.00

0.24

estimate

0.86

299

1593

(3013826) Glucose [Moles/volume] in Serum or Plasma

1216

9306

1.69

30.78

4.5

6.20

6.45

mmol/l

5.32

1131

8566

(3022948) Iron [Moles/volume] in Serum or Plasma

440

2528

1.93

30.21

2.3

2.4

13.29

14.47

umol/l

2.80

422

2371

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

148

534

2.90

30.14

1.7

2.0

0.24

0.23

g/l

0.49

140

503

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

219

962

2.42

30.05

2.3

1.6

—

(3032080) INR in Blood by Coagulation assay

853

5984

1.69

29.73

8.7

9.3

1.11

1.14

inr

1.41

702

4942

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

209

908

2.44

29.37

1.3

1.4

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

149

553

2.82

28.80

1.7

1.9

1.25

1.18

g/l

2.08

141

522

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

149

556

2.80

28.50

1.3

1.2

32.20

42.73

u/ml

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

879

6271

1.67

28.38

1.9

2.2

—

(3035933) Granulocytes/Leukocytes in Blood

118

390

3.14

28.02

4.3

3.1

56.71

57.60

0.38

118

390

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

725

4963

1.69

27.11

1.4

1.3

0.78

1.62

u/ml

3.26

214

1451

(3004789) Transferrin [Mass/volume] in Serum or Plasma

403

2326

1.90

27.01

2.2

2.4

2.44

2.41

g/l

0.73

381

2159

(3036071) Salmonella sp Ab [Titer] in Serum

6.10

25.96

1.1

—

(3021960) Folate [Moles/volume] in Serum or Plasma

593

3887

1.72

25.82

1.7

1.5

19.28

20.16

nmol/l

0.90

522

3424

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

137

517

2.76

25.64

1.4

1.3

2.87

6.97

u/ml

0.90

(3010144) Erythrocytes [#/volume] in Synovial fluid

101

5.25

25.55

1.6

1.4

6478.80

83740.36

e6/l

1.26

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

371

2121

1.90

25.48

1.9

1.8

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

136

514

2.75

25.38

1.3

1.2

1.12

3.82

u/ml

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

481

2986

1.78

25.30

2.7

3.1

586.81

939.51

ng/l

1.87

384

2454

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

367

2102

1.90

25.03

2.3

2.5

22.15

24.22

2.15

349

1968

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1270

10159

1.59

24.25

3.7

3.1

103.42

86.59

ug/l

0.67

1217

9696

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

160

671

2.49

24.19

1.2

1.3

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

1987

17928

2.11

24.16

15.4

11.7

139.57

139.62

mmol/l

0.49

1952

17506

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

577

3828

1.69

23.71

1.9

1.7

0.95

mg/l

0.02

423

2849

(3023103) Potassium [Moles/volume] in Serum or Plasma

1989

17990

2.10

23.43

15.6

11.8

3.92

mmol/l

0.04

1952

17515

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

868

6435

1.58

22.45

2.2

1.8

96.76

98.42

pmol/l

0.52

522

3536

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

264

1412

1.99

21.90

5.4

4.6

—

(3023368) Bacteria identified in Blood by Culture

535

3551

1.67

21.66

4.3

4.0

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

165

743

2.32

21.28

1.9

2.3

36.84

39.09

u/l

0.88

154

691

(3025941) Bacteria identified in Stool by Culture

211

1063

2.09

20.60

1.3

1.2

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

294

1666

1.88

20.48

2.5

2.1

365.15

382.05

nmol/l

0.60

273

1563

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

108

405

2.75

20.46

1.3

1.2

1.23

1.36

u/ml

—

(3020630) Protein [Mass/volume] in Serum or Plasma

184

886

2.17

20.18

1.8

2.6

68.14

67.30

g/l

0.79

168

833

(3019309) Folate [Moles/volume] in Red Blood Cells

331

1971

1.80

19.61

1.8

1.6

1186.29

1158.71

nmol/l

0.23

273

1522

(3007566) Smooth muscle Ab [Titer] in Serum

129

541

2.47

19.49

1.2

1.3

85.00

90.37

titre

0.10

(3004616) Nuclear Ab [Presence] in Serum

217

3.35

19.20

1.3

—

(3004588) Protein electrophoresis panel - Serum or Plasma

151

684

2.30

19.20

1.9

2.1

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

111

437

2.62

19.13

1.3

1.2

31.02

39.30

u/ml

0.28

(3013512) EKG study

639

4546

1.57

19.08

2.8

—

0.77

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

714

5250

1.53

18.21

2.5

3.3

2.34

2.35

mmol/l

1.06

655

4899

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

261

1487

1.86

17.77

1.7

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1913

17404

1.76

17.51

5.8

5.1

1.70

1.78

mu/l

2.95

1826

16509

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

403

2616

1.66

17.34

2.2

2.6

2.42

mmol/l

0.28

353

2351

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

251

1429

1.85

17.10

1.7

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

109

451

2.49

16.97

1.6

1.3

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

331

2.73

16.61

1.4

1.3

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

1828

16490

1.64

16.54

22.4

13.9

13.43

13.33

3.21

1821

16259

(3019225) pH of Specimen

230

1287

1.88

16.53

3.1

3.7

7.36

7.35

0.49

177

940

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

189

3.29

16.18

1.7

1.4

—

(3042936) Bacteria identified in Isolate by Culture

338

2131

1.69

16.17

2.2

1.9

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

123

551

2.31

16.06

1.3

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

190

3.27

16.04

1.7

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

190

3.27

16.04

1.7

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

177

3.34

15.76

1.6

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

177

3.34

15.76

1.6

1.5

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

178

3.32

15.63

1.6

1.4

—

(3026008) Bacteria identified in Urine by Culture

613

4480

1.51

15.62

3.0

2.4

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

109

473

2.37

15.31

2.0

2.4

10.71

10.91

mg/l

0.10

104

453

(3034891) Synovial lining cells/cells in Synovial fluid

5.93

15.26

1.4

1.3

1.20

1.15

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

106

458

2.38

15.04

1.2

1.1

—

(3007853) Bacteria identified in Skin by Aerobe culture

301

1874

1.70

15.03

2.0

1.6

—

(40768797) Stomach Pathology biopsy report

326

2076

1.67

14.95

1.2

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

298

2.71

14.86

1.4

1.9

0.54

0.71

g/l

0.92

234

(42529406) Shigella sp [Presence] in Stool by Culture

106

465

2.34

14.54

1.2

1.1

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

806

6296

1.44

14.38

3.6

3.1

31.90

31.24

u/l

0.15

769

5989

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

566

4129

1.50

14.35

2.1

2.2

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

163

3.31

14.25

1.3

1.4

0.41

g/l

0.03

113

(3027135) IgG subclass 1 [Mass/volume] in Serum

163

3.31

14.25

1.3

1.4

6.46

6.63

g/l

0.12

113

(3028192) IgG subclass 2 [Mass/volume] in Serum

164

3.29

14.12

1.3

1.4

3.21

2.99

g/l

0.32

115

(3014765) Yersinia sp identified in Stool by Organism specific culture

104

461

2.32

13.94

1.2

1.1

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1671

14952

1.49

13.79

5.1

4.3

14.52

14.44

pmol/l

0.83

1585

14033

(3007461) Platelets [#/volume] in Blood

2177

21003

4.35

13.75

31.5

17.3

272.90

259.72

e9/l

18.71

2163

20641

(40768443) Skin Pathology biopsy report

135

670

2.08

13.68

1.2

—

(3024731) MCV [Entitic mean volume] in Red Blood Cells

2177

21012

4.31

13.55

31.2

17.2

90.73

90.07

11.08

2172

20835

(3035941) MCH [Entitic mass]

2177

21013

4.30

13.53

31.2

17.2

30.19

30.10

1.65

2172

20836

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

2177

21015

4.29

13.48

31.7

17.5

40.72

40.97

0.55

2171

20824

(3026361) Erythrocytes [#/volume] in Blood

2177

21016

4.29

13.46

31.4

17.2

4.51

4.57

e12/l

6.77

2161

20618

(4062490) Immunoglobulin typing, IgG

159

3.26

13.44

1.3

1.4

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1004

8225

1.41

13.43

2.8

2.6

—

estimate

—

(3022621) pH of Urine by Test strip

232

1388

1.75

13.31

2.8

2.1

6.03

6.14

1.13

136

838

(3010813) Leukocytes [#/volume] in Blood

2177

21024

4.25

13.28

31.5

17.3

6.85

6.65

e9/l

3.15

2161

20613

(3000963) Hemoglobin [Mass/volume] in Blood

2177

21026

4.25

13.24

31.6

17.3

135.60

136.68

g/l

3.79

2172

20846

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

435

3067

1.52

12.80

1.7

1.6

50886492.67

37299338.99

pmol/l

0.16

395

2673

(3005322) IgE [Units/volume] in Serum or Plasma

228

1376

1.73

12.68

1.3

184.18

265.11

u/ml

0.55

217

1279

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

411

2.32

12.57

2.1

1.9

3.89

3.69

g/l

0.71

386

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

413

2.31

12.43

2.1

1.9

4.22

4.31

g/l

0.51

387

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

414

2.30

12.37

2.1

1.9

7.42

7.16

g/l

0.77

387

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

354

2.40

12.16

2.1

1.9

9.85

10.50

g/l

0.91

326

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

124

3.43

12.08

1.5

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

124

3.43

12.08

1.5

1.2

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

598

4536

1.44

12.07

2.1

2.3

—

(3020891) Body temperature

107

510

2.15

12.06

3.8

4.1

36.96

36.94

°c

0.26

107

503

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

150

3.18

11.95

1.2

1.1

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

150

814

1.90

11.82

2.5

2.0

4.38

8.04

ug/l

2.46

132

728

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

391

2.30

11.77

2.1

2.0

2.96

2.93

g/l

0.08

364

(3004809) Band form neutrophils/Leukocytes in Blood

206

2.81

11.68

2.3

3.3

0.98

1.40

0.59

194

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

544

4089

1.44

11.44

2.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

119

3.41

11.38

1.7

1.9

27.69

24.17

mg/l

0.15

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

171

2.97

11.32

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

148

3.08

10.91

1.2

1.1

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

197

2.78

10.90

1.1

1.5

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

194

1170

1.72

10.80

2.3

78.03

74.85

ml/min/173m2

0.53

476

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

3.81

10.76

1.3

1.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

682

5394

1.38

10.56

1.9

1.6

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

4.37

10.52

1.4

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

378

2.24

10.50

1.4

1.5

304.04

771.42

e6/l

0.43

289

(4034850) Laboratory test

464

2.12

10.48

10.6

6.7

—

(36660697) Celiac disease serology panel - Serum

257

1680

1.60

10.46

1.2

—

(3027945) Reticulocytes/Erythrocytes in Blood

223

1416

1.64

10.21

2.1

3.0

1.77

1.74

0.14

198

1288

(3019060) Gas panel - Arterial blood

117

615

1.95

10.16

5.1

5.8

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

437

2.13

10.11

1.3

1.4

17.74

23.57

u/l

1.15

366

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

4.23

10.10

1.4

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

161

946

1.76

9.83

3.6

4.0

68.64

80.56

ng/l

0.93

146

844

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

142

3.00

9.74

1.3

1.1

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

368

2.19

9.49

2.1

2.0

0.24

0.72

g/l

1.62

324

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

375

2.18

9.47

1.3

1.5

55.58

20.11

e6/l

0.61

269

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

145

2.93

9.40

1.3

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

146

2.91

9.29

1.3

1.1

—

(3017354) Segmented neutrophils/Leukocytes in Blood

130

3.04

9.28

1.8

2.7

53.62

54.42

0.09

119

(3008757) Leukocyte morphology finding [Identifier] in Blood

125

3.08

9.25

2.1

3.5

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

141

2.94

9.25

1.1

1.2

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

412

2.11

9.25

1.7

2.3

446.80

312.83

ug/l

0.19

387

(3037756) Immunofixation for Serum or Plasma

210

2.56

9.16

1.3

1.6

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

489

2.01

9.14

2.4

1.9

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

350

2517

1.46

9.11

3.5

3.0

279.47

500.19

ng/l

0.52

195

1545

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

5.03

9.09

1.0

1.1

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1832

17064

1.44

9.08

4.3

3.9

5.66

5.70

mmol/l

0.83

1728

16019

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

116

632

1.88

9.07

2.7

2.6

1.14

1.27

0.88

116

625

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

160

2.79

8.98

1.2

1.4

0.16

0.28

nmol/l

0.53

122

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1655

15162

1.37

8.98

3.9

3.5

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

211

1365

1.60

8.95

2.2

2.3

0.23

0.22

g/l

0.35

199

1304

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

275

1890

1.52

8.94

2.5

4.79

7.51

umol/l

5.94

241

1638

(3023520) Reticulocytes [#/volume] in Blood

166

1011

1.69

8.92

1.9

3.0

74.31

72.49

e9/l

0.25

122

723

(3003327) Ova and parasites identified in Stool by Light microscopy

135

782

1.77

8.67

1.5

1.6

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

157

950

1.70

8.65

1.3

1.2

—

(3033658) Prothrombin time (PT) actual/Normal

518

4026

1.37

8.65

3.5

3.7

95.31

94.57

0.33

504

3942

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

430

2.04

8.63

2.0

2.2

0.87

2.45

ug/l

1.38

391

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

311

2.22

8.58

2.2

1.8

0.00

g/l

-0.00

272

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

113

623

1.86

8.54

2.6

2.5

0.66

0.63

0.50

113

618

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

103

551

1.91

8.53

2.5

2.0

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

287

2.27

8.46

2.4

3.2

27.79

41.62

mg/l

0.75

245

(3052851) Hemolysis interference index of Serum or Plasma

380

2.09

8.40

2.2

3.0

0.89

1.91

index

1.60

213

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

319

2288

1.46

8.38

3.1

2.6

2.96

3.57

e6/l

0.39

164

1018

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

138

816

1.74

8.27

2.8

3.1

5.08

5.17

kpa

0.83

130

791

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

101

543

1.90

8.25

1.8

2.1

1.60

1.39

g/l

1.07

474

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

101

547

1.89

8.08

1.3

1.2

27.56

44.16

u/ml

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

261

2.30

8.07

1.1

1.2

162.50

198.67

titre

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

287

2.23

8.04

2.4

3.2

36.08

64.48

mg/l

0.73

243

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

262

2.29

8.00

1.1

1.2

—

94.29

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

145

878

1.70

7.98

1.5

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

368

2.07

7.94

1.1

—

(3018405) Lactate [Moles/volume] in Arterial blood

348

2.11

7.93

3.6

4.3

1.33

1.42

mmol/l

0.32

342

(3028433) Virus identified in Specimen by Culture

4.45

7.90

1.5

1.2

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

322

2339

1.44

7.89

3.1

3.6

0.82

0.83

mmol/l

0.70

302

2234

(3004716) Salmonella sp identified in Stool by Organism specific culture

184

1189

1.60

7.85

1.4

—

(3018333) Ribosomal P Ab [Presence] in Serum

138

2.78

7.81

1.3

1.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

161

2.64

7.79

1.3

—

nmol/l

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

239

1641

1.51

7.79

2.4

2599.45

6144.43

u/l

2.00

101

701

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

421

1.98

7.69

1.3

1.4

—

4.91

—

(40768804) Tissue Pathology biopsy report

851

7206

1.30

7.67

2.1

1.9

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

252

1755

1.49

7.66

4.7

6.3

1.04

mmol/l

0.03

232

1651

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

151

2.68

7.65

1.4

1.8

—

(3000494) Fungus identified in Specimen by Culture

291

2088

1.45

7.61

1.5

1.4

—

(3012544) pH of Venous blood

190

1248

1.57

7.57

3.7

3.6

7.38

0.02

716

(3024263) Appearance of Synovial fluid

3.82

7.52

2.5

2.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

141

2.72

7.52

1.3

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

4.25

7.47

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

195

2.44

7.44

1.1

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

399

1.99

7.40

1.6

1.3

270.32

303.08

ug/g

0.64

217

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1776

16606

1.36

7.32

5.1

4.8

36.62

37.62

mmol/mol

6.33

1694

15871

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

515

1.86

7.28

1.3

1.2

293.67

255.55

u/ml

0.50

322

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

255

2.23

7.19

2.5

2.9

1.33

1.90

ratio

0.97

139

(3002032) Base excess in Venous blood by calculation

182

1200

1.56

7.14

3.6

1.64

1.56

mmol/l

0.13

163

1033

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

330

2.06

7.06

2.8

—

(3009343) pH of Capillary blood

130

791

1.68

7.05

2.8

3.1

7.42

7.41

0.75

105

657

(3037121) Protein [Mass/volume] in Urine

528

1.84

7.05

2.8

3.4

265.79

360.19

mg/l

0.43

263

(3044927) Protein electrophoresis panel - Urine

3.17

6.99

1.1

1.2

—

(1761868) Lipid panel - Serum or Plasma

774

9023

0.78

6.91

2.5

2.6

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

3.65

6.75

1.2

1.3

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

238

2.21

6.62

1.5

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

7.82

6.61

1.6

2.1

4.10

2.93

mg/l

0.58

(3044640) Blood type and Crossmatch panel - Blood

664

5532

1.29

6.55

2.3

2.1

—

(3044290) Cell count panel - Cerebral spinal fluid

368

1.96

6.53

1.3

1.5

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

3.66

6.47

1.2

1.1

676.20

305.12

ng/l

—

(3022313) Gas panel - Capillary blood

558

1.77

6.45

2.9

3.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

364

1.95

6.38

1.5

1.7

292.84

386.00

mu/l

2.90

301

(3014148) Varicella zoster virus Ab [Titer] in Serum

403

1.89

6.22

1.1

1.2

—

(21494755) Public health laboratory ask at order entry panel

221

3044

0.70

6.08

1.3

—

(3012516) Albumin [Mass/volume] in Urine

514

4182

1.30

6.01

3.1

3.7

56.98

53.83

mg/l

0.12

295

2724

(4024509) Urine culture

111

680

1.67

5.91

1.8

1.7

—

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

5.80

5.83

1.2

40.43

43.33

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

104

632

1.68

5.72

2.3

2.2

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

244

1788

1.41

5.67

4.1

3.9

31.05

31.83

0.58

193

1297

(3009508) Creatinine [Moles/volume] in Urine

613

5133

1.27

5.66

3.2

3.6

8.07

8.13

mmol/l

0.10

521

4536

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

121

2.58

5.63

1.5

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

121

2.58

5.63

1.5

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

121

2.58

5.63

1.5

1.6

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

217

2.14

5.49

1.5

1.3

8.40

74.84

u/ml

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

161

1099

1.50

5.43

1.4

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

273

2.00

5.38

1.1

1.6

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

109

683

1.63

5.35

2.8

3.0

1.24

1.74

mmol/l

0.84

502

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

155

2.34

5.34

1.8

1.6

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

3.19

5.32

1.3

1.2

18.60

29.14

u/l

0.33

(3013139) Helicobacter pylori Ag [Presence] in Stool

172

1198

1.47

5.26

1.2

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

212

1536

1.42

5.26

2.7

4.6

213.09

238.29

u/l

3.14

197

1476

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

150

2.35

5.25

1.3

1.2

1.11

1.05

ratio

0.94

125

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

290

1.96

5.23

1.1

5.64

3.28

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

132

2.45

5.21

1.3

1.2

44.04

65.72

u/l

1.37

119

(3020911) Cortisol [Moles/time] in 24 hour Urine

3.14

5.19

1.2

1.4

85.03

97.19

nmol/24h

0.46

(3018677) aPTT in Platelet poor plasma by Coagulation assay

281

2139

1.36

5.19

2.1

29.63

29.23

0.53

269

2076

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

237

1756

1.39

5.17

1.3

1.2

95.43

149.37

u/ml

1.72

674

(3019977) pH of Arterial blood

188

1342

1.44

5.06

7.1

9.2

7.42

0.51

111

729

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

134

2.41

5.06

1.2

8.97

8.81

mm/h

0.02

134

(3026782) Osmolality of Urine

355

2809

1.31

5.04

2.9

2.6

533.10

533.95

mosm/kgh2o

0.02

320

2458

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

225

2.07

5.03

1.4

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

3.42

5.03

1.3

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

3.42

5.03

1.3

1.4

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

404

1.78

4.97

1.3

1.6

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

434

1.75

4.96

3.1

3.2

24.55

24.76

mmol/l

0.33

400

(3047181) Lactate [Moles/volume] in Blood

368

1.82

4.94

6.0

6.7

1.44

1.27

mmol/l

0.67

325

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

4.35

4.93

1.4

1.5

91.69

93.49

0.07

(3006653) Thiamine [Moles/volume] in Blood

2.88

4.92

1.2

1.4

145.96

126.22

nmol/l

1.14

(3000330) Specific gravity of Urine by Test strip

107

683

1.60

4.89

3.3

2.8

1.02

ratio

0.07

597

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

355

1.83

4.88

1.1

1.5

—

(3020682) Albumin/Creatinine [Ratio] in Urine

512

4270

1.26

4.79

3.6

4.4

10.24

9.89

mg/mmol

0.06

283

2777

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

380

1.79

4.76

1.3

1.6

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

4.43

4.74

1.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

126

2.40

4.73

1.2

1.1

1.63

1.05

u/l

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

172

2.17

4.63

1.1

—

(3027801) Oxygen [Partial pressure] in Arterial blood

184

1331

1.42

4.62

7.2

9.2

12.91

13.53

kpa

0.81

179

1291

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

184

1331

1.42

4.62

7.2

9.2

5.03

kpa

0.01

178

1291

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

209

1550

1.38

4.54

2.5

2.3

39.60

70.92

u/l

0.51

176

1338

(3049717) Cytology report of Urine Cyto stain

298

1.87

4.53

2.1

2.4

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

395

1.74

4.47

2.7

6.3

1762.00

727.48

iu/ml

—

(3016502) Oxygen saturation in Arterial blood

164

1170

1.43

4.45

7.5

10.0

96.22

96.25

0.02

157

1137

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

173

1249

1.42

4.40

1.1

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

2.74

4.35

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

2.74

4.35

1.7

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

2.74

4.35

1.7

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

2.74

4.35

1.7

—

(3033099) Centromere Ab [Titer] in Serum

3.97

4.29

1.0

1.2

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

145

2.22

4.28

1.0

1.1

1291.79

1434.43

miu/ml

0.38

145

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

120

2.35

4.25

1.1

1.2

—

(3010838) Calcium [Moles/time] in 24 hour Urine

276

1.87

4.24

2.2

2.0

5.40

5.24

mmol/24h

0.11

248

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

114

765

1.52

4.23

1.6

1.7

12.02

11.43

u/ml

0.05

240

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

494

1.64

4.22

1.4

1.5

—

(40761536) Microorganisms panel - Urine sediment

206

1544

1.37

4.21

4.2

3.2

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

4.14

4.20

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

4.14

4.20

1.1

1.2

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

140

2.23

4.18

1.9

1.7

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

6.95

4.16

1.0

1.2

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

5.26

4.14

1.0

1.1

0.03

0.02

u/ml

0.43

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

5.90

4.13

1.0

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

2.81

4.12

1.1

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1813

17334

1.26

4.11

3.7

3.5

1.23

1.24

mmol/l

0.25

1725

16456

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

2.72

4.09

1.4

1.1

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

153

1097

1.42

4.06

2.8

3.3

1.23

mmol/l

0.10

140

934

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

369

1.73

4.06

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

4.21

4.01

1.2

1.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

104

693

1.53

4.00

1.4

1.3

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

3.91

3.99

1.0

1.1

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1511

14192

1.21

3.99

3.5

2.9

41.47

38.41

u/l

0.80

1441

13656

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

371

1.72

3.99

1.6

1.5

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

105

703

1.52

3.95

1.8

1.5

—

(3003396) Base excess in Arterial blood by calculation

180

1335

1.38

3.94

7.2

9.1

0.95

0.79

mmol/l

0.23

148

1102

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

536

1.59

3.91

1.2

1.1

3.76

4.38

0.46

102

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

7.30

3.86

1.0

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.96

3.79

1.2

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

160

2.08

3.77

1.1

—

(4211845) Urine protein measurement

2.74

3.75

4.4

2.2

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

5.02

3.68

2.0

2.7

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

169

2.03

3.65

1.1

—

(3015956) Eosinophils/Leukocytes in Blood by Manual count

4.42

3.62

2.1

1.9

2.27

1.54

0.88

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

4.02

3.59

1.0

1.3

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

572

1.54

3.59

1.1

1.97

5.72

eliau/ml

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

189

1435

1.35

3.58

2.6

2.3

12.68

12.87

nmol/l

0.12

180

1340

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

109

752

1.47

3.58

3.9

3.7

24.31

23.97

mmol/l

0.75

109

745

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

3.06

3.53

1.2

1.3

—

(3006462) Nitrate [Presence] in Urine

2.82

3.52

4.1

2.3

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

2.67

3.39

1.7

1.3

0.29

0.28

g/l

0.16

(3047007) Chlamydophila sp Ab [Presence] in Serum

320

1.70

3.39

1.3

1.2

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

253

1.79

3.38

1.1

1.2

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

2.58

3.38

1.4

2.3

256.45

166.17

umol/l

0.19

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1922

18598

1.26

3.31

4.8

4.5

2.80

2.85

mmol/l

1.75

1829

17738

(3026389) Candida sp identified in Specimen by Organism specific culture

257

1.77

3.22

1.4

1.3

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

530

1.53

3.22

2.1

2.4

5.22

6.18

umol/l

0.45

401

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

356

1.65

3.21

1.2

4.40

3.02

u/ml

0.27

135

(3002079) Sodium [Moles/time] in 24 hour Urine

2.51

3.21

1.6

1.2

141.67

173.12

mmol/24h

0.77

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

5.35

3.19

1.9

1.7

—

(3005011) Chlamydia sp Ab [Titer] in Serum

3.81

3.18

1.4

1.5

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

405

1.60

3.15

1.1

13.96

14.15

au/ml

0.01

138

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

506

4390

1.20

3.11

1.6

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

3.44

3.10

1.2

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

2.39

3.06

3.4

3.5

23.06

22.21

ug/l

0.07

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

472

1.54

3.05

1.3

1.4

158.52

143.12

au/ml

0.49

118

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

5.01

3.05

1.1

1.4

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

5.85

3.02

1.1

1.3

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

287

2358

1.25

3.01

1.8

2.0

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

2.36

2.98

1.2

1.1

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

302

1.67

2.97

1.1

1.4

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

106

757

1.42

2.95

3.1

2.8

158.76

150.67

ng/l

0.08

669

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

4.72

2.92

1.1

1.3

—

(44813793) Dust mix specific IgE antibody measurement

142

1.98

2.90

1.2

1.0

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

686

1.43

2.86

1.7

1.5

—

(3011985) Renin [Units/volume] in Plasma

223

1.76

2.82

2.1

1.6

50.55

53.05

mu/l

0.04

204

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

307

1.64

2.80

1.7

3.2

—

2144.00

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.55

2.78

1.1

1.2

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

2.37

2.72

1.1

2.0

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1093

0.68

2.72

1.6

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1066

0.68

2.68

1.5

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.22

2.68

1.1

1.2

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

426

1.52

2.58

1.9

1.8

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1900

18462

1.21

2.51

4.4

4.1

4.70

4.76

mmol/l

2.13

1821

17688

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.17

2.51

1.2

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

3.47

2.48

2.8

1.9

—

(3005033) Fetal Nuchal fold Thickness US

1049

0.70

2.47

1.5

1.34

1.26

0.94

763

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

2.20

2.47

1.9

1.8

1.40

5.40

u/field

—

(3000991) Gas panel - Venous blood

146

1133

1.31

2.46

7.2

9.5

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.68

2.45

1.3

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

181

1.78

2.44

1.2

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.90

2.41

1.2

—

(3014007) Fractional oxyhemoglobin in Arterial blood

102

758

1.36

2.31

8.3

11.9

94.32

94.47

0.07

102

753

(40768441) Liver Pathology biopsy report

133

1.89

2.31

1.3

1.4

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

2.76

2.27

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

2.76

2.27

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

2.76

2.27

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

2.76

2.27

1.0

1.1

—

(3045142) Bone marrow Pathology biopsy report

156

0.32

2.27

2.0

1.5

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

135

1.86

2.22

1.1

1.3

0.70

0.68

ratio

0.05

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1890

18397

1.19

2.22

4.3

4.1

1.47

1.48

mmol/l

0.20

1803

17541

(44790048) Parainfluenza type 2 nucleic acid detection

202

1.69

2.21

1.1

1.6

—

(44806118) Parainfluenza type 4 nucleic acid detection

202

1.69

2.21

1.1

1.6

—

(44790047) Parainfluenza type 1 nucleic acid detection

202

1.69

2.21

1.1

1.6

—

(44790049) Parainfluenza type 3 nucleic acid detection

202

1.69

2.21

1.1

1.6

—

(3020779) Urea [Moles/volume] in Serum or Plasma

147

1161

1.29

2.20

6.2

8.2

8.19

7.79

mmol/l

0.31

138

1124

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

102

766

1.35

2.18

8.1

11.6

1.29

1.27

0.05

102

760

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

265

1.60

2.18

1.4

1.7

—

(3023511) Choriogonadotropin [Units/volume] in Urine

103

775

1.35

2.18

1.5

1.3

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

100

751

1.35

2.14

8.3

11.8

0.71

0.64

0.94

100

746

(3009214) Lutropin [Units/volume] in Serum or Plasma

113

869

1.32

2.07

1.6

1.4

9.37

8.91

u/l

0.14

702

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

318

2745

1.19

2.06

3.5

3.8

1.34

1.88

ug/l

2.49

295

2523

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

167

1352

1.25

2.05

3.1

3.7

4.67

4.60

pmol/l

0.18

153

1234

(21494890) Protein electrophoresis panel - 24 hour Urine

1.99

2.05

1.8

1.9

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

202

1671

1.23

2.05

1.5

1.4

18.82

23.05

iu/l

1.44

182

1422

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

143

1137

1.28

2.04

1.4

1.3

241.59

229.73

miu/ml

0.15

562

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

413

3648

1.16

2.02

1.6

1.5

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

140

1.79

2.01

1.2

1.3

840.00

1080.00

titre

—

(37208534) Antinuclear antibody arbitrary concentration in serum

2.29

1.97

1.0

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

137

1090

1.27

1.96

2.6

3.0

23.28

58.68

u/ml

2.30

129

1060

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.99

1.95

1.2

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

330

2873

1.17

1.94

2.1

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

4.55

1.94

1.0

1.2

0.01

0.94

u/ml

—

(3001729) Color of Synovial fluid

4.55

1.94

2.6

2.0

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

1.96

1.90

1.0

8.28

11.29

u/ml

0.33

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

128

1.81

1.90

1.5

1.7

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

146

1.72

1.77

1.1

1.3

185.44

167.12

pmol/l

0.29

146

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

2.92

1.72

1.1

1.7

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

127

1.74

1.64

1.1

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

323

2850

1.16

1.62

1.7

1.8

1.44

1.38

0.45

287

2598

(3000060) B lymphocytes [#/volume] in Blood

2.15

1.61

1.3

2.1

0.18

0.16

e9/l

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

289

3286

0.86

1.60

1.8

3.45

3.50

ratio

0.25

212

2411

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

206

1.56

1.59

4.3

5.4

25.61

116.28

u/ml

0.79

(3050129) First trimester maternal screen panel - Serum or Plasma

187

1579

1.20

1.59

1.4

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

106

1.80

1.58

1.8

2.0

2.00

2.19

u/field

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

106

1.80

1.58

1.2

1.9

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

492

1.35

1.56

1.0

1.1

4.71

3.91

u/ml

0.10

247

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

2.28

1.55

1.1

1.9

42.75

41.86

g/l

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

122

1.73

1.54

1.4

2.0

—

(3012501) Base excess in Blood by calculation

274

1.47

1.52

3.0

3.2

2.66

2.32

mmol/l

0.26

172

(3023410) Appearance of Cerebral spinal fluid

185

1.58

1.51

1.1

1.7

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

1.95

1.48

1.0

1.1

12.46

7.34

u/ml

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

163

1.60

1.46

1.2

1.3

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

2.04

1.43

2.1

1.8

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

2.04

1.43

2.1

1.8

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

2.04

1.43

2.2

1.8

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

649

1.29

1.43

1.1

0.78

2.52

u/ml

3.20

330

(3002619) Bacteria identified in Specimen by Culture

2.31

1.43

1.1

1.0

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

245

1.48

1.42

1.4

1.8

—

(4268621) Lupus anticoagulant assay

246

1.47

1.40

2.0

2.3

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

2.26

1.40

1.0

2.0

—

(40768795) Lymph node Pathology biopsy report

178

0.50

1.39

1.3

1.2

—

(3042631) Mycobacterium sp identified in Specimen

134

1.65

1.39

3.0

—

(3019832) Treponema pallidum Ab [Presence] in Serum

462

4218

1.12

1.38

1.7

1.9

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

0.00

1.34

0.0

3.0

—

2.10

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

245

2152

1.16

1.33

2.9

3.2

20.71

21.24

0.20

732

(3023430) Cat dander IgE Ab [Units/volume] in Serum

454

1.33

1.32

1.0

1.1

2.33

4.45

u/ml

1.19

205

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

1.81

1.31

1.5

1.7

26.13

30.02

umol/l

0.62

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.78

1.28

1.0

1.2

1.42

1.82

umol/24h

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

122

1.65

1.27

2.8

2.6

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.01

1.27

1.1

—

(3001556) Androgen free Index in Serum or Plasma

2.29

1.27

1.0

1.2

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

154

1.56

1.26

1.0

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

555

1.29

1.26

1.0

1.1

2.34

1.54

u/ml

0.28

274

(3032773) Endomysium IgG Ab [Titer] in Serum

203

1.48

1.25

1.1

—

titre

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

2.00

1.23

3.1

2.4

—

(3052592) Norovirus Ag [Presence] in Stool

2.64

1.21

2.8

1.3

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

115

1374

0.83

1.19

1.5

62.82

60.53

ug/l

0.18

102

1153

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

223

2523

0.87

1.18

1.6

3.46

3.48

mmol/l

0.13

142

1673

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

2.11

1.18

2.1

2.7

0.63

0.62

mmol/l

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

117

1.63

1.18

1.2

1.5

20.25

22.62

umol/l

0.15

108

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

781

7379

1.09

1.17

1.8

1.36

1.37

mmol/l

0.06

671

6505

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

157

1.53

1.17

1.2

1.4

—

(1616796) Gas panel - Central venous blood

282

1.39

1.16

2.5

3.2

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

2.00

1.16

1.0

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

107

1283

0.83

1.16

1.4

1.5

0.99

0.95

ratio

0.63

768

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

107

1283

0.83

1.16

1.4

1.5

1.24

1.21

ratio

0.13

774

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.50

1.15

2.8

2.6

0.60

1.00

u/field

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

107

1281

0.83

1.14

1.4

1.5

1.28

1.16

ratio

0.49

766

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.34

1.12

1.1

3.0

—

(3023419) Bacteria identified in Sputum by Culture

143

1.54

1.11

2.2

3.2

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

1.71

1.11

1.3

1.2

16.87

21.15

u/l

0.19

(3020876) Protein [Mass/time] in 24 hour Urine

168

1.49

1.09

1.9

2.7

0.63

1.53

g/24h

2.70

110

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

122

1032

1.19

1.09

1.7

1.8

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

185

1.47

1.08

1.1

1.7

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

417

1.30

1.08

1.0

0.04

0.24

u/ml

1.81

123

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

356

1.33

1.07

1.2

3.37

3.68

u/ml

0.16

161

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

144

1238

1.17

1.07

2.9

4.6

4.96

23.49

ug/l

1.52

110

937

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.12

1.05

1.3

1.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

607

1.24

1.04

1.8

2.3

2.72

12.55

iu/l

0.62

278

(3003888) Timothy IgE Ab [Units/volume] in Serum

589

1.25

1.04

1.0

1.1

6.93

5.50

u/ml

0.20

321

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

187

1.45

1.03

1.1

8.64

15.20

u/ml

—

106

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

107

1267

0.84

1.03

1.4

1.5

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

106

1.61

1.02

1.8

2.8

46.22

44.38

—

(3044242) Glucose [Moles/volume] in Arterial blood

1.74

1.02

1.3

2.8

9.05

9.01

mmol/l

0.01

(44816559) Phosphatidylethanol [Mass/volume] in Blood

113

956

1.19

1.02

1.4

1.6

0.26

0.31

mg/l

0.37

449

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

600

1.24

1.02

2.2

2.5

3.87

3.61

g/l

0.79

570

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

1.88

1.00

1.9

4.3

1.67

1.22

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

104

1229

0.84

0.99

1.0

1.1

0.49

0.63

ratio

—

120

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

223

1.40

0.98

1.1

1.5

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

2.18

0.98

1.2

1.4

1.12

1.32

umol/l

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

559

1.24

0.96

1.7

1.5

0.36

0.43

nmol/l

0.39

455

(3004451) EKG impression Narrative

1.78

0.94

1.3

1.2

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

117

1.54

0.93

6.9

8.1

12.02

15.09

ug/l

0.11

(3006442) Creatine [Moles/volume] in Serum or Plasma

117

1.54

0.93

1.4

1.2

71.17

75.65

umol/l

0.67

117

(3010937) Rubella virus Ab [Presence] in Serum

2.15

0.91

1.2

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

110

1.55

0.90

1.7

1.9

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

385

1.28

0.89

1.1

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

457

1.25

0.89

3.0

4.2

60.95

642.16

u/ml

1.23

401

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

101

859

1.18

0.89

7.3

8.7

24.70

24.67

mmol/l

0.03

101

854

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

119

1.52

0.88

1.5

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.86

0.87

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.86

0.87

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.86

0.87

1.0

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

596

1.22

0.85

2.1

2.4

180.39

179.83

0.02

575

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

326

1.29

0.85

1.2

1.3

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

1.67

0.85

1.0

1.1

106.43

92.90

—

(4146454) Self-monitoring of blood glucose

104

1.54

0.84

2.4

2.7

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.70

0.80

1.1

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

140

1.43

0.77

1.3

2.4

31.50

32.16

0.27

140

(3008295) Osmolality of Serum or Plasma

157

1.41

0.76

1.4

1.7

279.47

284.25

mosm/kgh2o

0.74

126

(3051611) Lipemic interference index of Serum or Plasma

132

1.44

0.76

3.2

3.3

15.33

14.51

index

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.70

0.75

1.2

—

(3034426) Prothrombin time (PT)

1.65

0.75

1.2

27.64

28.78

0.35

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

175

1.38

0.74

1.1

1.7

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.67

0.74

1.6

1.5

8.17

7.85

ug/l

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

126

1110

1.14

0.74

1.5

1.9

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

273

2517

1.10

0.73

1.9

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

676

0.82

0.72

1.3

—

(1617658) Protocol used for examination of sentinel lymph nodes

159

0.63

0.72

1.0

1.1

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

335

1.26

0.72

1.8

2.1

132.52

132.88

g/l

0.04

278

(3014271) Vancomycin [Susceptibility]

1.93

0.70

2.0

2.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

564

1.19

0.70

1.0

1.1

0.69

1.22

u/ml

0.81

247

(40768793) Breast Pathology biopsy report

510

1.20

0.69

1.3

—

(3020650) Glucose [Presence] in Urine

1.60

0.68

2.6

1.3

0.00

estimate

-0.00

(3017569) Oxygen content in Arterial blood

1.60

0.68

1.5

3.1

15.25

16.98

0.67

(3028308) Erythrocytes [#/volume] in Pleural fluid

1.54

0.65

1.5

1.4

92256.67

18539.70

e6/l

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.59

0.65

1.4

2.4

—

(1002224) Polysomnography panel

132

1180

1.13

0.64

1.1

—

(40768800) Prostate Pathology biopsy report

127

0.63

0.64

1.0

1.2

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

173

1.33

0.61

1.2

1.1

8.79

8.87

iu/ml

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

1.59

0.61

1.2

2.0

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

1.59

0.61

1.2

2.0

—

(4038314) Semen analysis, post vasectomy

1.67

0.61

1.2

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

126

1128

1.12

0.61

1.5

1.6

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

389

1.21

0.60

1.4

1.2

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

0.00

0.60

0.0

1.1

—

(3036489) Thrombin time

714

1.15

0.60

1.8

2.0

19.59

20.53

1.53

612

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.50

0.59

1.1

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.50

0.59

1.1

1.0

0.12

1.90

u/ml

0.86

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

102

904

1.13

0.58

1.5

51.77

61.72

ug/l

2.31

102

904

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

549

1.17

0.57

2.8

3.6

1.35

1.31

mg/l

0.16

519

(3051387) C reactive protein [Mass/volume] in Capillary blood

353

0.79

0.57

2.4

3.1

22.19

24.69

mg/l

0.17

237

(3001019) Free T4 and TSH panel - Serum or Plasma

143

1572

0.90

0.55

1.8

1.6

—

(3026250) Tacrolimus [Mass/volume] in Blood

0.61

0.52

55.8

41.5

6.63

7.51

ug/l

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

154

1411

1.10

0.51

3.6

2.6

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.41

0.51

1.4

2.1

14.10

16.12

umol/l

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

101

1.39

0.49

1.1

1.6

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

372

1.19

0.48

1.2

1.3

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

346

1.19

0.46

1.1

1.0

0.89

3.01

eliau/ml

2.81

199

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.43

0.46

3.0

4.5

4.64

4.92

kpa

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.43

0.46

3.0

4.5

10.71

10.73

kpa

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

120

0.67

0.45

1.0

1.3

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

1.45

0.44

1.1

1.2

102.70

115.84

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

208

0.77

0.44

2.1

1.8

—

(3042517) Benzodiazepines panel - Urine

1.61

0.43

2.0

3.1

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.61

0.43

1.0

1.2

1.19

1.18

mmol/l

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

468

0.85

0.43

1.7

1.6

—

(4094501) Cardiovascular stress test using bicycle ergometer

414

0.84

0.42

1.1

—

(3017704) Immunofixation for Urine

1.43

0.42

1.6

1.8

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.65

0.42

1.0

1.1

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.56

0.42

1.0

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

176

1.25

0.41

1.4

1.2

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

1.43

0.41

3.8

2.8

0.64

1.16

ug/l

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

0.00

0.41

0.0

1.2

—

9.22

—

(3007463) Buprenorphine [Presence] in Urine

0.00

0.41

0.0

4.6

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.00

0.40

0.0

1.0

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

0.00

0.40

0.0

2.6

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

0.39

0.0

1.5

—

40.61

—

(40765089) Chromosome analysis panel - Blood by G-banded

148

0.74

0.38

1.0

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.35

0.38

1.1

1.4

—

(3039443) Prostate specific Ag panel - Serum or Plasma

234

1.20

0.37

1.5

—

(4281824) Cell count and differential, peritoneal fluid

180

0.78

0.36

1.1

—

(3047189) Immunofixation for 24 hour Urine

1.43

0.35

1.3

1.7

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

298

0.84

0.35

3.2

3.7

36.30

23.94

u/ml

0.35

290

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

312

1.16

0.33

3.3

3.4

0.37

0.36

iu/ml

0.08

157

(3011288) Drugs identified in Urine by Screen method Nominal

118

1098

1.08

0.32

4.0

3.1

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

1.35

0.32

1.0

1.4

—

78.00

—

(3012565) Volume of 24 hour Urine

1.33

0.32

2.2

2.3

2160.91

1878.28

0.34

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

101

1.29

0.31

3.6

3.7

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.72

0.31

3.4

3.2

40.00

44.29

—

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

0.72

0.31

6.9

6.5

8.00

8.32

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

166

1.21

0.29

1.6

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

322

0.87

0.27

1.5

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

1.25

0.27

1.0

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

300

0.87

0.27

5.2

3.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

108

1012

1.07

0.26

1.5

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

135

1278

1.06

0.25

1.8

1.7

303.26

296.00

mu/l

0.09

123

1155

(3045788) Cell count panel - Pleural fluid

1.18

0.24

1.6

1.3

—

(40768446) Kidney Pathology biopsy report

0.73

0.24

2.7

1.6

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

152

1.19

0.23

1.2

1.3

0.03

1.46

u/ml

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.28

0.23

1.2

1.1

—

(40768806) Pleura Pathology biopsy report

0.76

0.22

1.1

1.5

—

(4035726) Immunohistochemistry procedure

129

1356

0.95

0.22

1.4

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

1.1

—

(3007456) Orange IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.13

—

(3026726) Creatinine [Moles/volume] in Specimen

0.00

0.21

0.0

2.6

—

245.67

—

(3000093) Morphology [Interpretation] in Blood Narrative

126

1.19

0.21

1.2

1.1

—

(3051339) Copper [Moles/volume] in Blood

0.00

0.21

0.0

1.1

—

15.59

—

(3029396) Erythrocyte agglutination [Presence] in Blood

123

0.81

0.20

3.4

3.1

—

(3011325) HIV 1+2 Ab [Presence] in Serum

0.00

0.20

0.0

1.1

—

0.08

—

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

0.00

0.20

0.0

1.4

—

12.40

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

234

2417

0.96

0.19

1.5

1.6

994.08

1014.18

mu/l

0.12

203

2052

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

178

1715

1.04

0.19

2.1

2.5

0.55

0.68

ug/l

2.69

823

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.13

0.18

1.0

1.8

—

(4195642) Thrombophilia screening test

341

0.91

0.17

1.3

1.2

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

504

1.07

0.17

1.6

1.5

73.54

143.37

pmol/l

1.21

494

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

253

1.11

0.17

1.3

1.2

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

253

1.11

0.17

1.3

1.2

—

(21494814) CD8 cells/Lymphocytes in Specimen

1.16

0.16

1.4

2.2

23.50

29.33

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

1.14

0.15

1.2

1.7

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

1.13

0.15

1.1

1.2

49.67

63.96

ug/l

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

1.19

0.14

1.2

1.6

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

0.81

0.13

1.6

1.5

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

365

1.07

0.12

1.1

—

(3028707) Methadone [Presence] in Urine by Screen method

630

1.05

0.12

3.8

3.2

—

(3003694) ABO and Rh group [Type] in Blood

654

6476

1.01

0.10

1.6

1.7

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

594

1.05

0.10

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

1.14

0.10

3.6

5.5

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

1.15

0.09

1.2

—

(3022689) Creatine [Moles/volume] in Urine

1.04

0.09

1.0

1.5

13.12

9.43

mmol/l

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

233

1.07

0.09

1.4

1.6

—

(3002256) Pathology report gross observation

231

2271

1.02

0.08

1.2

—

(3041806) Other cells [#/volume] in Blood by Manual count

175

0.91

0.08

1.6

1.5

0.55

0.50

e9/l

0.44

175

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.03

0.07

1.0

1.6

67.57

91.97

ng/l

—

(3042733) HLA Ab [Presence] in Serum

0.84

0.07

2.5

4.9

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.86

0.07

1.0

1.1

27.10

41.15

iu/ml

—

(3012441) Differential panel - Pleural fluid

1.03

0.07

1.3

1.4

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

167

1.08

0.06

1.3

1.1

108.28

116.28

pmol/l

0.31

167

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

304

0.95

0.05

1.9

2.8

242.46

79.97

ug/min

0.57

197

(4198724) Urine methamphetamine measurement

141

0.92

0.05

2.8

2.4

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

149

1.07

0.05

1.4

1.5

10.80

10.51

umol/l

0.07

138

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

337

1.04

0.05

1.6

1.7

7.82

7.55

mmol/l

0.36

323

(1001926) Buprenorphine [Presence] in Urine by Screen method

128

1261

1.02

0.04

2.7

2.2

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

161

1.06

0.03

1.2

1.5

1.27

1.26

promille

0.01

129

(3016879) Cocaine [Presence] in Urine

149

1505

0.99

0.03

2.6

2.2

—

(3003740) Influenza virus B Ag [Presence] in Specimen

559

1.02

0.03

1.1

—

(3027944) Amphetamines [Presence] in Urine

160

1614

0.99

0.02

2.6

2.1

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

168

0.95

0.02

1.7

—

(3002523) Influenza virus A Ag [Presence] in Specimen

560

1.02

0.02

1.1

—

(3000764) Benzodiazepines [Presence] in Urine

163

1620

1.01

0.01

2.5

2.2

—

(44806420) Estimation of glomerular filtration rate

263

1.03

0.01

2.2

2.1

—

(3025130) Human papilloma virus identified in Specimen

496

0.99

0.00

2.3

1.9

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.05

0.00

1.0

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

119

1.01

0.00

1.5

1.2

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

345

0.99

0.00

1.1

15.60

1467.56

iu/ml

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

209

1.00

0.00

1.0

1.1

—

(3027008) Opiates [Presence] in Urine

163

1625

1.00

0.00

2.4

2.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

939

1.00

0.00

2.1

1.8

4.53

4.58

mg/l

0.02

653

(3028300) Cannabinoids [Presence] in Urine

163

1632

1.00

0.00

2.6

2.2

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

213

0.99

0.00

2.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

187

1.02

0.00

1.0

1.1

0.03

3.13

u/ml

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.0

1.0

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

0.00

0.0

2.6

—

(4212803) Bone marrow aspirate examination

0.00

0.0

1.0

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

51.12

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

0.00

0.0

1.0

—

202.20

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.0

5.1

—

476.78

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.1

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

0.0

4.3

—

(3016228) CD19 cells/cells in Blood

0.91

0.00

1.2

2.2

5.83

7.08

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.0

5.0

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

0.0

1.2

—

(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.5

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

6.6

—

(40760409) HLA-A [Type] by High resolution

0.00

-0.00

0.0

1.0

—

(3013862) HLA-DP [Type]

0.00

-0.00

0.0

1.0

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

7.9

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

200

1.00

-0.00

1.1

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

-0.00

0.0

1.0

—

(3051651) Icteric interference index of Serum or Plasma

0.93

-0.00

2.2

3.5

2.22

0.79

index

—

(40763590) HLA-DQ beta [Type]

0.00

-0.00

0.0

1.0

—

(3036525) Urea [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.3

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1.01

-0.00

1.2

1.6

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

1.66

—

(3047185) IgG [Mass/volume] in Urine

0.00

-0.00

0.0

1.0

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

0.00

-0.00

0.0

1.1

—

7.99

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

0.00

-0.00

0.0

1.1

—

(46236302) HLA-C [Type] by High resolution typing

0.00

-0.00

0.0

1.0

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.3

—

(40760410) HLA-B [Type] by High resolution

0.00

-0.00

0.0

1.0

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

-0.00

0.0

2.7

—

118.17

—

Mortality – FinRegistry

↥

Association

Association between endpoint M13_SACROILIITIS and mortality.

Females

Parameter	HR [95% CI]	p-value
M13_SACROILIITIS	1.026 [0.86, 1.22]	0.771
Birth year	1.0 [0.99, 1.01]	0.952

During the follow-up period (1.1.1998 — 31.12.2019), 189 out of 5262 females with M13_SACROILIITIS died.

Males

Parameter	HR [95% CI]	p-value
M13_SACROILIITIS	1.109 [0.93, 1.32]	0.239
Birth year	0.988 [0.98, 1.0]	0.009

During the follow-up period (1.1.1998 — 31.12.2019), 161 out of 3252 males with M13_SACROILIITIS died.

Mortality risk

Mortality risk for people of age

years, who have M13_SACROILIITIS.

N-year risk	Females	Males
1	0.093%	0.222%
5	0.627%	1.331%
10	1.608%	3.293%
15	3.278%	6.163%
20	5.972%	10.583%

Relationships between endpoints

↥

Index endpoint: M13_SACROILIITIS – Sacroiliitis, not elsewhere classified

GWS hits: 6

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Sacroiliitis, not elsewhere classified

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints